Dissertations / Theses: 'NNos'

1

Simmers, Jessica L. "nNos localization, muscle function and atrophy in skeletal muscle disorders." Thesis, The Johns Hopkins University, 2013. http://pqdtopen.proquest.com/#viewpdf?dispub=3573097.

Full text

Abstract:

In skeletal muscle, loss of neuronal nitric oxide synthase (nNOS) from the sarcolemma has been observed in a few muscular dystrophies and myopathies. However, the extent of this phenomenon, its mechanism, and its physiological impact are not well understood. Using immunofluorescent staining for nNOS, a survey of 161 patient biopsies found absent or reduced sarcolemmal nNOS in 43% of patients. Patient mobility and muscle functional status correlated with nNOS mislocalization from the sarcolemma. Mouse models of inherited and acquired myopathies showed similar loss of sarcolemmal nNOS and impaired mobility and muscle function. A proteomic approach, using mass spectrometry and differentially labeled control and steroid-induced myopathy (SIM) mouse samples, found novel nNOS binding proteins including alpha-actinin-3 (ACTN3), which exhibited decreased interaction with nNOS after steroid treatment. It revealed a potential explanation for impaired muscle function in SIM as nNOS interactions were lost at the sarcomere and gained at the sarcoplasmic reticulum impairing contractility. Treating nNOS-deficient mice with steroids demonstrated that loss of sarcolemmal nNOS reduces muscle contractility and strength in SIM through increased nitric oxide (NO) signaling. In SIM mice treated with a nitric oxide donor and steroids, nitric oxide partially protects the muscle from atrophy and improves muscle fatigability and recovery suggesting nNOS mislocalization also decreases NO availability. These findings show that loss of sarcolemmal nNOS is a common phenomenon that negatively impacts muscle function. Therapeutic strategies targeting nNOS or NO signaling need to allow for the complexity of local nitric oxide content and cellular context.

APA, Harvard, Vancouver, ISO, and other styles

2

BALDELLI, SARA. "Ruolo dell'ossido nitrico sintasi neuronale (nNOS) nella modulazione dell'omeostasi redox intracellulare." Doctoral thesis, Università degli Studi di Roma "Tor Vergata", 2009. http://hdl.handle.net/2108/861.

Full text

Abstract:

L' ossido nitrico (NO) è una molecola in grado di svolgere funzioni diverse e contrapposte in dipendenza della sua concentrazione e del sito di produzione: ad alte concentrazioni (? M-mM) può provocare effetti tossici, mentre a basse concentrazioni (nM) può funzionare da secondo messaggero e da antiossidante. Per chiarire i meccanismi attraverso i quali l' NO esplica la sua funzione di antiossidante e di mantenimento dell' omeostasi cellulare, abbiamo esaminato gli effetti del trattamento con derivati organosolfurici dellâ aglio (DADS e GE), in grado di incrementare i livelli intracellulari di ROS in cellule di neuroblastoma umano SH-SY5Y, che esprimono costitutivamente la nNOS. I seguenti studi ci hanno dimostrato che i derivati organosolfurici dell' aglio potrebbero modulare il contenuto di nNOS e suggeriscono come l' NO potrebbe svolgere un importante ruolo nel bloccare la citotossicità indotta dai ROS. Accanto all' azione antiossidante dell'NO, ogni cellula presenta un sistema di difesa antiossidante indispensabile nel bloccare lo stress ossidativo/nitrosativo. In particolare, il sistema nervoso rappresenta una regione dell' organismo altamente aerobia e i livelli della sua difesa antiossidante sono relativamente bassi, si ipotizza, quindi, che la nNOS con il suo prodotto NO e gli antiossidanti intracellulari, interagiscano allo scopo di mantenere l'equilibrio della cellula nervosa. La SOD1 e il GSH rappresentano due degli antiossidanti che potrebbero interagire in modo diretto o indiretto con la nNOS o con l' NO, a livello del sistema nervoso. I seguenti studi propongono come un flusso endogeno di NO, dovuto a sovraespressione dell' enzima nNOS, possa influenzare l' omeostasi cellulare e l' espressione di un antiossidante intracellulare, il GSH. Infine, abbiamo mostrato come la nNOS, attraverso un meccanismo NO-indipendente, sembra regolare negativamente la trascrizione del gene che codifica per la SOD1, interagendo direttamente con il fattore di trascrizione Sp1 impedendo il suo legame al promotore del gene sod1 e down-regolando, così, il suo contenuto in mRNA, l' attività e il contenuto proteico.
Nitric oxide (NO) plays an important role in both physiological and pathophysiological mechanisms involving properties at the chemical, cellular, and physiological levels. The relatively low concentration of NO required being an antioxidant suggests that in addition to its involvement with cyclic GMP, this radical molecule serves to counterbalance oxidative stress. This balance between NO and oxidative stress provides an important regulatory mechanism in numerous physiological effects. Imbalance in this redox symbiotic relationship can lead to different pathophysiological conditions. Here we demonstrate the neuroprotective role played by nNOS/NO in counteracting the ROS-mediate ciotoxicity, induced by treatment with garlic derivatives. In particular, we found that, besides their role in promoting growth arrest and apoptosis, either oil-soluble derivatives DADS or water GE significantly increased the content of nNOS in neuronal cell lines. Next to the antioxidant action of NO, each cell is equipped with an extensive antioxidant system to counteract their harmful properties directly by interception or indirectly through reversal of oxidative damage. In central nervous system, the antioxidant defence system and nNOS may interact to ensure the integrity and homeostasis of neuronal cells. Especially in the nervous system the nNOS/NO may directly or indirectly modulate the activity and expression of antioxidant defence systems. Indeed, we further analysed the influence of endogenous overproduction on NO on the intracellular antioxidants SOD1 and GSH in cell lines of neuronal and non-neuronal origin. We report that nNOS over-expression induced a NO-dependent increase in the concentration of GSH thus reinforcing the idea that it represents a protective agent against NO cytotoxicity. On the other hand, the nNOS over-expression causes a NO-indipendent down-regulation of SOD1 in terms of mRNA, protein and activity levels.

APA, Harvard, Vancouver, ISO, and other styles

3

SAGRATI, ANDREA. "Neuronal nitric oxide synthase positive cells in the human corpus callosum and indusium griseum." Doctoral thesis, Università Politecnica delle Marche, 2021. http://hdl.handle.net/11566/291083.

Full text

Abstract:

L’obbiettivo del nostro studio è stato quello di comprendere il meccanismo che controlla la regolazione del flusso sanguigno cerebrale nel corpo calloso (CC) umano con il fine di spiegare l’effetto BOLD, precedentemente scoperto da Fabri e collaboratori nel 2011. Le analisi per determinare la presenza, il numero, la distribuzione e la morfologia delle cellule immunopositive all’enzima ossido nitrico sintetasi neuronale (nNOS) sono eseguite sul corpo calloso e sul’indusium griseum (IG). L’Ossido nitrico (NO) è un neurotrasmettitore gassoso largamente diffuso nel cervello umano ed ha, tra le altre funzioni, un potente effetto vasodilatante e perciò contribuisce a regolare il flusso sanguigno cerebrale. Sezioni seriali sagittali ottenute da blocchetti in paraffina e da taglio del tessuto in congelato sono state utilizzate per l’analisi immunoistochimica sul CC e sul IG. L’intensa marcatura che si è ottenuta ha dimostrato la presenza di cellule immunopositive al nNOS, e grazie alla microscopia a fluorescenza ne è stata confermata la loro natura neuronale e astrocitaria. Cellule neuronali immunopositive all’nNOS sono state osservate sia nel CC che nell’IG mentre gli astrociti che lo esprimono erano solo presenti nel CC. I neuroni nNOS positivi hanno mostrato diverse morfologie e risultavano essere piu abbondanti a 1mm a partire dalla linea mediana, per l’IG e a 4mm per il CC con un picco di massima abbondanza nel corpo del CC. In alcuni casi questi nueroni erano localizzati principalmente nell’interfaccia tra IG e CC e piu specificatamente in prossimita delle arterie piali, arteriole che originano dall’arteria sopracallosale che poi si affosano nel corpo calloso. La presenza di neuroni nNOS positivi in prossimità di vasi sanguigni, in questi due tessuti suggeriscono un loro plausibile ruolo nella regolazione neurovascolare del CC che potrebbero quindi ipoteticamente spiegare l’effetto BOLD osservato in risonanza. l’IG inoltre potrebbe giocare un ruolo attivo nel controllo della vascolarizzazione del CC, ed è quindi probabile e che non sia solo un tessuto di rimanenza embrionale come precedentemente si riteneva ma un tessuto con un sua funzione specifica. Infine è stata osservata per la prima volta la presenza di astrociti nNOS positivi nel corpo calloso umano. Queste cellule variavano nella presenza, nel numero e nelle loro distribuzione in base a diverse condizioni di ossigenazione sistemica che avvenivano nel momento del decesso. Infatti nei soggetti deceduti dopo una breve ipossia gli astrociti nNOS positivi erano assenti, mentre risultavano essere molto abbondanti nei soggetti deceduti con un ipossia prolungata. L’immunopositività degli astrociti sembrerebbe quindi essere correlata alla durata dell’ipossia cerebrale al momento della morte.
The aim of the present study is to investigate the possible mechanism for the control of cerebral blood flow in the corpus callosum (CC), that could explain the BOLD effect previously found (Fabri et al., 2011). The presence, number, distribution and morphology of neuronal Nitric Oxyde Sinthase (nNOS) positive cells was investigated in the corpus callosum (CC) and indusium griseum (IG). Nitric Oxyde (NO) is a gaseous neurotransmitter largely diffused in the brain, whichexerts a powerful vasodilatory effect, and therefore it can contribute to regulate the cerebral blood flow. Sagittal serial sections from paraffin or frozen autoptic specimens of human adult CC and overlying IG were processed for immunohistochemistry and immunofluorescence analysis, using an antibody against the neuronal form of the enzyme Nitric Oxyde Synthase (nNOS). The stainings revealed the presence of many nNOS immunopositive cells. By double labeling technique with immunofluorescence at confocal microscopy, it has been shown that in the CC both neurons and astrocytes positive to nNOS antibody were present, and their number varied in different conditions, as detailed below. In the IG, only neurons nNOS positive were found. Neurons showed different morphologies, were more numerous 1 mm apart from the medial line in IG and 4 mm in CC, with a peak over the body of the CC. In some cases, they were located at the boundary between IG and CC, more densely packed in proximity to the pial arteries penetrating into the CC. The significant presence of nNOS immunopositive neurons in these two structures suggests that they might have a role in the neurovascular regulation of CC, moreover the IG could plays a functional role in the adult brain. The presence of nNOS positive astrocytes in the human CC has been here demostrated for the first time. As previously mentioned, their number and distribution varied in different conditions: nNOS positive astrocytes were absent in samples from subjects deceased after a short hypoxia; their number and labeling intensity increased with the hypoxia prolongation. Neuronal NOS immunopositivity of CC astrocytes seems thus related to the hypoxia duration and the consequent brain damage.

APA, Harvard, Vancouver, ISO, and other styles

4

Cheung, Nathan Yiutung. "Serotonin receptor and neuronal nitric oxide synthase expression in the rat brain : implications for MDMA toxicity." Thesis, King's College London (University of London), 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.368095.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Jähne, Sebastian [Verfasser]. "Kompensationsmechanismen im Skelettmuskel von neuronaler Stickstoffmonoxid-Synthase (nNOS) defizienten Mäusen / Sebastian Jähne." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2010. http://d-nb.info/1027814905/34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Lim, Gregory B. S. "nNOS-derived nitric oxide modulation of the ryanodine receptor calcium release channel." Thesis, University of Oxford, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.533867.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

McNamara, Tanner. "ENOS and nNOS contribution to reflex cutaneous vasodilation during dynamic exercise in humans." Thesis, Kansas State University, 2012. http://hdl.handle.net/2097/13788.

Full text

Abstract:

Master of Science
Department of Kinesiology
B.J. Wong
Recent data suggests nNOS mediates the NO-component of reflex cutaneous vasodilation with passive heat stress. Our hypothesis was nNOS, but not eNOS, inhibition would attenuate reflex cutaneous vasodilation during dynamic exercise. Protocol 1: subjects performed a VO[subscript]2 peak test on a supine cycle ergometer. Protocol 2: with experimental arm at heart level subjects cycled in supine posture at 60% VO[subscript]2 peak to raise core temperature (Tc) 0.8-1.0°C (35-45 min). In protocol 2 subjects were equipped with 4 microdialysis fibers on the forearm and each randomly assigned as: 1) lactated Ringer’s (control); 2) 5mM NPLA (nNOS inhibition); 3) 10mM L-NIO (eNOS inhibition); and 4) 20mM L-NAME (non- selective NOS inhibition). At the end of protocol 2 all sites were locally heated to 43°C and infused with SNP to elicit maximal dilation. Mean arterial pressure (MAP), skin blood flow via laser- Doppler flowmetry (LDF), and Tc via ingestible telemetric pill were measured; cutaneous vascular conductance (CVC) was calculated as LDF/MAP and normalized to maximum. In protocol 2 there was no significant difference between control (62±5 %CVCmax) and NPLA (61±6 %CVCmax). L-NIO (38±4 %CVCmax) and L-NAME (41±7 %CVCmax) significantly attenuated CVC compared to control and NPLA (p<0.001 all conditions). There was no difference between L-NIO and L- NAME. We conclude eNOS, not nNOS, contributes to reflex cutaneous vasodilation during dynamic exercise.

APA, Harvard, Vancouver, ISO, and other styles

8

Sangüesa, Ferrer Juan F. "Modulation fonctionnelle et distribution du canal calcique Cav3. 2 : rôle de la nNOS." Montpellier 1, 2008. http://www.theses.fr/2008MON1T015.

Full text

Abstract:

Le canal calcique Cav3. 2 joue un rôle capital dans de nombreux processus physiologiques, notamment dans la transmission de la douleur aigüe et chronique. Cependant, les mécanismes régulant la distribution et les propriétés de ces canaux restent encore mal connus. Au cours de ma thèse, j'ai participé au développement d'un nouveau modèle pour étudier ces mécanismes : la souris knock-in Cav3. 2-GFPécliptique. Cette souris permettra d'étudier la localisation et la dynamique de Cav3. 2 in vivo grâce à une étiquette fluorescente insérée dans la partie extracellulaire du canal. Des sites de recombinaison loxP ont été également introduits dans le génome de cette souris afin d'effectuer des invalidations tissu-spécifiques et/ou inductibles du canal. En parallèle, une approche protéomique m'a permis d'identifier un nouveau partenaire de Cav3. 2 : la nNOS, une enzyme responsable de la production d'oxyde nitrique (NO). En effet, nous avons montré que Cav3. 2 possède un motif très conservé dans sa région C-terminale qui lui permet d'interagir avec le domaine de PDZ de la nNOS. Cette interaction a des conséquences fonctionnelles pour les deux protéines. D'une part, la présence de la nNOS induit une diminution de la densité des courants générés par le canal Cav3. 2, grâce à un mécanisme qui nécessite l'activité de l'enzyme et la présence d'un centre coordinateur d'ions métalliques dans la partie extracellulaire du canal. D'autre part, nous avons montré que Cav3. 2 est capable de modifier la distribution subcellulaire de la nNOS. L'enzyme est emmenée par le canal à proximité de la membrane plasmique où elle est plus facilement activée par l'entrée de calcium. Cette association fonctionnelle Cav3. 2-nNOS pourrait être impliquée dans des processus comme la nociception, la mémoire et la régulation du tonus vasculaire.

APA, Harvard, Vancouver, ISO, and other styles

9

Sato, Vinicius Antonio Hiroaki. "Participação da serotonina no efeito tipo-antidepressivo induzido pela inibição da nNOS no hipocampo de ratos." Universidade de São Paulo, 2011. http://www.teses.usp.br/teses/disponiveis/17/17133/tde-22062011-090727/.

Full text

Abstract:

Introdução: O óxido nítrico (NO) tem sido relacionado como um importante neuromodulador envolvido com a neurobiologia da adaptação ao estresse e da depressão. De fato, a administração sistêmica ou intra-hipocampal de inibidores da NO sintase neuronial (nNOS) induz efeitos do tipo antidepressivo em modelos animais. Evidências recentes indicam que os efeitos sistêmicos dos inibidores da nNOS são dependentes dos níveis de serotonina no encéfalo. O sistema serotoninérgico do hipocampo dorsal, por ativação dos receptores serotoninérgicos do tipo 1A (5HT1A), facilita a adaptação ao estresse e contribui para os efeitos comportamentais de drogas antidepressivas. Portanto, o objetivo do presente estudo foi testar a hipótese de que o efeito do tipo antidepressivo induzido pela administração hipocampal de inibidores da nNOS seria mediado pela facilitação da neurotransmissão serotoninérgica local e subseqüente ativação de 5HT1A. Métodos: Após cirurgia estereotáxica, ratos Wistar com cânulas-guia direcionadas ao hipocampo dorsal foram submetidos a sessão de pré-teste (PT 15 minutos de nado) e receberam administrações locais das drogas: N-propil-L-arginina (NPA, inibidor seletivo da nNOS: 0,00001 - 1 nmol/0,5 µL), fluoxetina (SSRI: 1, 3 e 10 nmol/0,5 µL), WAY100635 (antagonista seletivo para 5HT1A: 1, 3 e 10 nmol/0,5 µL) ou veículo (0,5 µL). 24h depois, o tempo de imobilidade foi registrado em uma sessão de 5 minutos de nado. Todos os protocolos foram aprovados por um comitê de ética local (Proc. No 08.1.1133.53.4) Resultados: A administração intra hipocampal de NPA ou fluoxetina reduziu significativamente o tempo de imobilidade em animais submetidos ao teste do nado forçado, um efeito tipo antidepressivo. A administração de WAY100635 não induziu efeito por si, mas foi capaz de bloquear os efeitos induzidos por fluoxetina ou NPA. Conclusões: A inibição da nNOS, pelo NPA, ou a inibição da recaptação de serotonina, pela fluoxetina, no DH induziu efeito do tipo antidepressivo de similar magnitude. O fato de que o pré-tratamento com WAY100635 foi capaz de bloquear os efeitos induzidos por NPA e fluoxetina indica que ambos os efeitos são mediados por facilitação da neurotransmissão serotoninérgica local e subseqüente ativação de 5HT1A. Assim, esses resultados sugerem que níveis aumentados de NO no DH poderiam levar a um déficit na neurotransmissão serotoninérgica local e, portanto, predispor ao desenvolvimento das conseqüências comportamentais do estresse.
Introduction: Nitric oxide (NO) has been suggested to play an important role in the neurobiology of stress adaptation and depression. In fact, systemic or hippocampal administration of neuronal NO synthase (nNOS) inhibitors induces antidepressant-like effects in animal models. Recent evidence indicates that the systemic effects of nNOS inhibitors are dependent on serotonin levels in the brain. The serotonergic system of the dorsal hippocampus (DH), through the activation of serotonin 1A (5-HT1A) receptors, is proposed to mediate stress adaptation and the behavioral effects of antidepressant drugs. Therefore, the aim of the present study was to test the hypothesis that the antidepressant-like effects induced by nNOS inhibition into the hippocampus would be mediated by a facilitation of the local serotonergic neurotransmission and subsequent 5-HT1A receptor activation. Methods: Male Wistar rats with guide-cannulae aimed at the DH were submitted to the pretest session (PT - 15 minutes of swimming) and received local administrations of the drugs: n-propyl-L-arginine (NPA, selective nNOS inhibitor: 0.00001 - 1 nmol/0.5 µL), fluoxetine (SSRI: 1, 3 and 10 nmol/0.5 µL), WAY100635 (selective 5-HT1A antagonist: 1, 3 and 10 nmol/0.5 µL) or vehicle (0.5 µL). One day later, the immobility time was registered at a 5 minutes swimming test session. All protocols were approved by a local ethical committee (Proc. N. 08.1.1133.53.4.) Results: The intrahippocampal administration of NPA or fluoxetine reduced the immobility time in animals submitted to the forced swimming test, an antidepressant-like effect in this model. WAY100635 did not induce any effect per se, but it was able to block the effects induced by fluoxetine or NPA. Conclusions: Inhibition of nNOS, by NPA, or inhibition of serotonin reuptake, by fluoxetine, in the DH induced antidepressant-like effects of similar magnitude. The fact that pretreatment with WAY100635 was able to block NPA- and fluoxetine-induced effects indicates that both effects are mediated by a facilitation of the local serotonergic neurotransmission and subsequent activation of 5-HT1A receptors. Therefore, these results suggest that increased NO levels in the DH could impair local serotonergic neurotransmission and, thus, predisposes to the development of stress-induced behavioral consequences, such as depressive-like behaviors.

APA, Harvard, Vancouver, ISO, and other styles

10

Sato, Vinicius Antonio Hiroaki. "Substratos neurais envolvidos com o desenvolvimento do comportamento de desamparo em ratos: possível envolvimento do NO." Universidade de São Paulo, 2015. http://www.teses.usp.br/teses/disponiveis/17/17133/tde-20072016-091556/.

Full text

Abstract:

Recentemente, o óxido nítrico (NO) tem sido relacionado com a depressão. A administração de inibidores da NO sintase (NOS) induz efeitos do tipo antidepressivo em modelos animais e há um aumento da expressão da NOS em estruturas do sistema límbico em indivíduos depressivos e em animais expostos a estresse. Além disso, sabe-se que o estresse causa um aumento da ativação de neurônios localizados em estruturas do sistema límbico e que o tratamento com antidepressivos bem como com inibidor da NOS, diminui essa marcação. Contudo, ainda não se sabe como o sistema nitrérgico dessas estruturas está relacionado com os comportamentos relacionados à depressão. Assim nosso objetivo é testar a hipótese de que o desenvolvimento do desamparo (comportamento relacionado à depressão) em ratos seria causado por um aumento de atividade de neurônios que contém nNOS em estruturas envolvidas com a resposta emocional ao estresse, e que os diferentes tratamentos induzem efeitos do tipo antidepressivo no modelo apresentando através de um efeito final comum de diminuir essa ativação e, portanto, diminuir os níveis de NO. Para isso, ratos foram submetidos ao modelo do desamparo aprendido e tratados com drogas antidepressivas. Após o teste, foi feita a imunohistoquímica com marcação para Fos (Fos-IR; marcador de atividade neuronal) e nNOS (nNOS-IR). O tratamento repetido com desipramina (DES, na dose de 25, mas não na de 12,5 mg/Kg), fluoxetina (FXT, na dose de 15, mas não na de 30 mg/Kg) e imipramina (IMI, 15mg/Kg) induziu efeito do tipo-antidepressivo no teste do desamparo aprendido (LH). O tratamento agudo apenas com imipramina, mas não com FXT ou IMI, induziu o mesmo tipo de efeito. O tratamento com DES, FXT ou IMI também aumentou o número de cruzamentos entre choques no LH, porém não induziu aumento de atividade locomotora no teste do campo aberto. O tratamento repetido com DES diminuiu a Fos-IR na amígdala basolateral (BlAm), amígdala lateral (LAm), córtex pré-frontal medial (mPFC), região CA1 e CA3 do hipocampo dorsal (dHPC) e região CA3 do hipocampo ventral (vHPC). O tratamento agudo com DES induziu um aumento de Fos-IR na amígdala central (CeAm), amígdala medial (MeAm) e CA1 e CA3 do dHPC. O tratamento repetido com FXT diminuiu Fos-IR na BlAm e LAm, enquanto o tratamento agudo aumentou Fos-IR na CeAm. O tratamento repetido com IMI aumentou nNOS-IR na MeAm e a dupla marcação no núcleo leito da estria terminal (BST); e diminuiu o Fos-IR na região CA1 do dHPC e na região parvocelular do núcleo paraventricular do hipotálamo (pPVN). Por fim, foram encontradas relações positivas entre o número de células Fos-IR e o número de falhas em fugir ou escapar dos choques no LH na BlAm, LAm, CA1 e CA3 do dHPC e CA3 do vHPC; i.e., quanto mais células ativadas nessas estruturas, maior o número de choques que os animais receberam sem consegui fugir. Os resultados aqui apresentados são, em parte, corroborados pela literatura, mostrando a participação das estruturas analisadas no comportamento do desamparo aprendido e no efeito das drogas antidepressivas. Nesse contexto, acredita-se que o BST funcionaria como um núcleo de processamento da informação vinda do mPFC, HPC e amígdala, enviando projeções para o PVN e regulando o funcionamento do eixo HPA. O trabalho abre caminho para a identificação de subpopulações específicas de neurônios que expressam a nNOS, buscando compreender o papel destas na modulação das respostas comportamentais numa situação de estresse, na busca pela formulação de um cenário cada vez mais completo da participação do sistema nitrérgico dentro do complexo neurocircuito que regula as emoções
Recently, nitric oxide (NO) has been related with the neurobiology of depression. The NO synthase (NOS) inhibition induces antidepressant-like effects in animal models and there is an increase in the NOS expression in limbic structures of depressed patients or in stress exposed animals. Besides, it is well known that stressful events causes an increase in limbic structures neuronal activation and that antidepressant treatment as well as NOS inhibition attenuates this effect. However, it is still unknown how the limbic nitrergic system is related with depression-related behaviors. Then, the aim of this work is to test the hypothesis that the helplessness behavior development (a depression-related behavior) in rats would be induced by an increased activity of nNOS-containing neurons in structures related with the neurobiology of stress responses. Furthermore, the antidepressant-like effect induced by antidepressants treatment in this model would share a final effect, decreasing the activation of such neurons, and decreasing the levels of NO in these structures. For this aim, male rats were submitted to the learned helplessness model and treated with antidepressants. After the test, immunohistochemistry assay were performed, with double labeling for c-Fos (Fos-IR; neuronal activity marker) and nNOS (nNOS-IR). The repeated treatment with desipramine (DES, 25 mg/kg but not 12,5mg/kg), fluoxetine (FXT, 15 mg/Kg, but not 30 mg/Kg) and imipramina (IMI, 15 mg/KG) induced antidepressant-like effects in the learned helplessness test (LH). The acute treatment with IMI, but not with DES or FXT, induced the same effect. The repeated treatment with DES, FXT or IMI also increased the number of intertrial crossings in the LH, but not the locomotor activity score on the open field score. The repeated treatment with DES decreased the number of Fos-IR into the basolateral amygdala (BlAm), lateral amygdala (Lam), medial prefrontal cortex (mPFC), CA1 and CA3 regions of the dorsal hippocampus (dHPC), and CA3 region of the ventral hippocampus (vHPC). The acute treatment with DES increased the Fos-IR into the central amygdale (CeAm), medial amygdala (MeAm), and CA1 and CA3 regions of the dHPC. The repeated treatment with FXT decreases the number of Fos-IR into the BlAm and Lam, while the acute treatment increases the Fos-IR into the CeAm. The repeated treatment with IMI increased the nNOS-IR into the MeAm and the double- labeled cells into the bed nucleus of stria terminalis (BST); and decreased the Fos-IR into the CA1 region of the dHPC and into the parvocellular region of the paraventricular nucleus of the hypothalamus. Finally, positive correlations between the number of Fos-IR and the number of failures in escaping or avoiding the foot shocks on the LH were found into the BlAm, Lam, CA1 and CA3 of the dHPC, and CA3 of the vHPC, i.e., with more activated cells into these structures mentioned, more foot shocks the rats received. These results are (partially) corroborated with previous scientific papers, showing the analyzed structures participation in the learned helplessness behavior as well as in the antidepressant effect of antidepressant administration. Within this context, the BST would work as a relay center, processing the information coming from the mPFC, HPC and amygdaloid nuclei, and sending the output to the PVN, modulating the HPA axis. This work open some questions about the identification of specific nNOS-containing neuronal subpopulations, aiming to clarify their role in the stress response, and searching for the formulation of a more complete scenario of the nitrergic system participation in this complex emotion-regulating neurocircuit

APA, Harvard, Vancouver, ISO, and other styles

11

Santos, Jaqueline Rocha Borges dos. "Participação da enzima nNOS na sensibilização cruzada entre estresse e etanol em camundongos Swiss." Universidade de São Paulo, 2013. http://www.teses.usp.br/teses/disponiveis/42/42136/tde-15032014-084536/.

Full text

Abstract:

O objetivo deste trabalho foi investigar alterações comportamentais produzidas por etanol (ET) e estresse crônico imprevisível (ECI) em camundongos adolescentes (ADL) e adultos (AD), estudando a participação da enzima nNOS. Em camundongos AD também estudamos a atividade da nNOS via receptor NMDA na sensibilização cruzada entre estresse por imobilização (EI) e ET, utilizando dizocilpina (DZP) como pré-tratamento. Os resultados demonstraram haver sensibilização cruzada entre ECI e ET, tanto nos ADL quanto nos AD. Houve aumento da atividade da nNOS em hipocampo (HP) e córtex frontal (CF) de AD submetidos ao ECI. ET atenuou este efeito. A sensibilização cruzada em ADL aumentou atividade da nNOS em CF. O pré-tratamento com 7-nitroindazol inibiu sensibilização cruzada entre ECI e ET em ADL e AD, sinalizando a participação da nNOS. DZP potencializou sensibilização cruzada entre EI e ET e diminuiu a atividade da nNOS em HP e CF de animais submetidos ao EI. ECI e EI induzem sensibilização comportamental ao ET e nNOS participa na sensibilização cruzada entre ECI/EI e ET.
The objective of this work was to investigate behavioral alterations produced by ethanol (ET) and chronic unpredictable stress (CUS) in adolescent (ADL) and adult (AD) mice, studying the nNOS enzyme activity. In AD mice was also studied the nNOS activity through the NMDA receptor in the cross-sensitization between immobilization stress (IS) and ET, by using dizocilpine (DZP) as a pretreatment. The results demonstrate cross-sensitization between CUS and ET in the ADL and AD mice. There was an increase in the nNOS activity in hippocampus (HP) and frontal cortex (FC) of AD submitted to CUS. This effect was attenuated by ET. The cross-sensitization in ADL increased the nNOS activity in FC. The 7-nitroindazole pretreatment inhibit cross-sensitization between CUS and ET in ADL and AD, signaling the nNOS participation. DZP potentiates cross-sensitization between IS and ET and decreased the nNOS activity in HP and FC of animals submitted to IS. CUS and IS induce behavioral sensitization to the ET and nNOS participate in the cross-sensitization between CUS/IS and ET.

APA, Harvard, Vancouver, ISO, and other styles

12

Lu, Chieh-Ju. "Neuronal nitric oxide synthase-CAPON regulation of cardiac sympathetic activity in the development of hypertension." Thesis, University of Oxford, 2015. http://ora.ox.ac.uk/objects/uuid:1204dec9-9f09-458d-b361-c8d14589fcd1.

Full text

Abstract:

The studies presented in this thesis were undertaken to investigate the cellular and molecular mechanisms responsible for sympathetic hyperactivity that is observed in the Spontaneous Hypertensive Rat (SHR) and whether these abnormalities arise even before the onset of hypertension. Moreover, selected molecular candidates related to oxidative state in cardiac autonomic signalling have been explored for their potential therapeutic effects. Chapter One is an overview of (i) the relevance of autonomic dysfunction in cardiovascular disease in both human and animal models, (ii) the physiological basis of cardiac sympathetic neurotransmission, (iii) the neuromodulators of peripheral cardiac sympathetic-vagal balance discussed along with how they may be involved in cardiac adrenergic control of neurotransmission and NO-cGMP signalling. This develops the formulation of the specific aims of the thesis. Chapter Two outlines a detailed rationale for the experimental approach taken to (i) characterise protein expression in the pre-hypertensive animal model with immunohistochemistry and Western blotting, (ii) manipulate selected gene expression to amplify NO-cGMP signalling in vivo and in vitro via viral gene transfer, (iii) investigate calcium handling in cardiac sympathetic stellate neurons with calcium imaging , (iv) measure cardiac noradrenergic neurotransmission from double atria using radioactive-labelled [³H]-noradrenaline. Chapter Three demonstrated abnormal NO-cGMP signalling in pre-hypertensive SHRs. Endogenous nNOS protein residing in both cardiac parasympathetic and sympathetic neurons was significantly lower in the pre-hypertensive SHR compared to aged-matched WKYs. This was associated with lower cGMP levels. An enhanced depolarization evoked [Ca²⁺]i transient was observed in cardiac stellate neurons from pre-hypertensive SHR when compared with the WKY, an effect that was reversed by nNOS or sGC inhibition. Chapter Four investigated the role of nNOS and brain natriuretic peptide (BNP) in cGMP signalling pathways. Gene transfer of nNOS via adenoviral vector in SHR cardiac sympathetic neurons increased cGMP concentration and normalised neuronal calcium handling during depolarization. BNP significantly reduces [3H]- noradrenaline release. Overexpression of PDE2 which facilitates the breakdown of cGMP caused an increase in [³H]- noradrenaline release in response to field stimulation and also prevented the inhibitory action of BNP. Chapter Five examined the role of the nNOS adaptor protein, CAPON in NO-cGMP signalling. Endogenous CAPON protein is present in cardiac sympathetic neurons in the WKY, and is significantly reduced in pre-hypertensive SHR cardiac neurons. Artificial up-regulation of cardiac sympathetic CAPON via targeted gene transfer directly attenuated neuronal Ca²⁺ transients, resulting in decreased noradrenaline release in the SHR. Chapter Six is a concluding discussion summarising the main findings from this thesis, placing them in a physiological context and discussing avenues for further research.

APA, Harvard, Vancouver, ISO, and other styles

13

Eisenhauer, Astrid. "Die kognitiven Defizite in einem Sepsismodell bei Ratten sind auf eine Herunterregulierung der nNOS zurückzuführen." [S.l.] : [s.n.], 2003. http://deposit.ddb.de/cgi-bin/dokserv?idn=970030274.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Molza, Anne-Elisabeth. "Etude in silico du complexe impliquant le domaine central de la Dystrophine, le domaine PDZ de la nNOS, l'Actine filamenteuse et les Phospholipides membranaires." Thesis, Rennes 1, 2015. http://www.theses.fr/2015REN1B018.

Full text

Abstract:

La dystrophine est une très grande protéine codée le gène DMD et située sous la membrane plasmique des fibres musculaires. Elle joue un rôle essentiel dans le maintien de l’intégrité de la cellule musculaire lors des cycles de contraction/relaxation. Cette protéine filamenteuse est composée de quatre domaines structuraux dont le domaine central composé de 24 répétitions homologues à la spectrine. Chaque répétition est organisée en faisceau de trois α-hélices appelé « coiled-coil ». Des mutations du gène DMD sont à l’origine des myopathies de Duchenne (DMD) et de Becker (BMD) qui s’accompagnent d’un déficit total ou d’une dystrophine mutée et induisent de ruptures fréquentes de la membrane des cellules musculaires. La connaissance de la structure de la dystrophine est nécessaire au développement de thérapies à ce jour inexistantes pour les myopathies. Au laboratoire, des données structurales du domaine central de la dystrophine ont été acquises par diffusion des rayons X aux petits angles (SAXS, Small Angles X-ray Scattering). Cette thèse présente le développement d’une approche multi-échelle combinant des données expérimentales SAXS et des données in silico pour la reconstruction de modèles haute-résolution des fragments du domaine central de la dystrophine et d’un fragment muté observé dans une mutation BMD fréquente. Nous avons également cartographié l’interaction de ce domaine central avec deux de ses partenaires fonctionnels importants, l’actine filamenteuse et avec la nitroxyde synthase neuronale (nNOS) et proposé les premiers modèles atomiques des complexes macromoléculaires correspondants. L’ensemble de ces résultats permettra à terme l’optimisation de thérapies pour le traitement des dystrophies musculaires
Dystrophin is a large protein encoded by DMD gene and located under the plasma membrane of muscle fibers. It plays an essential role in maintaining the integrity of muscle cells during contraction/relaxation cycles. This filamentous protein is composed of four structural domains including the central domain consisting of 24 spectrin-like repeats and four hinges. Each repetition is folded in three α-helices in a ‘coiled-coil’ assembly. Mutations in the DMD gene leads to Duchenne muscular dystrophy (DMD) and Becker (MDBs), which are accompanied by frequent plasma membrane ruptures, due to the loss or modification of dystrophin protein. There are very few structural data available concerning the central domain of dystrophin, which is subject to many mutations involved in DMD and BMD diseases. However, the description and the understanding to an atomic level of dystrophin structure and its interaction is essential for optimization of therapies. Given the impossibility to solve its structure by X-ray crystallography or NMR, structural data of the dystrophin central domain were acquired by small angles X-rays scattering (SAXS, Small Angles X-ray Scattering). This thesis presents the development of an innovative multi-scale approach combining experimental SAXS and in silico derived data, allowing the reconstruction of high-resolution models of dystrophin central domain fragments. Structural data were also obtained on a mutated dystrophin frequently observed in BMDs. Furthermore, we also mapped the interactions of the central domain with two of its majors functional partners, Filamentous actin and neuronal nitroxyde synthase (nNOS) and proposed models of the related macromolecular complexes. At long-term, all of these results will allow optimization of therapies for the treatment of muscular dystrophies

APA, Harvard, Vancouver, ISO, and other styles

15

Given, Alexis. "Models of Epsilon-Sarcoglycan Gene Inactivation and their Implications for the Pathology of Myoclonus Dystonia." Thèse, Université d'Ottawa / University of Ottawa, 2013. http://hdl.handle.net/10393/23790.

Full text

Abstract:

Myoclonus Dystonia (MD) is an autosomal dominant movement disorder characterized by bilateral myoclonic jerks paired with dystonia 1. Mutations have been mapped to the ε-sarcoglycan (SGCE) gene in about 40% of patients 2,92. The purpose of this project was to examine the properties of SGCE in the central nervous system (CNS) and use this knowledge to elucidate the pathology of MD. Although Sgce is a member of the sarcoglycan complex (SGC) in other tissues, little is known about its interactions in the CNS. The vast majority of mutations in SGCE alter the translational reading frame. Proteins arising from these rare mutations are less stable than the wild type (WT) and undergo preferential degradation via the ubiquitin proteasome system 3. As this locus is maternally imprinted, patients with MD are effectively null for sgce expression 73,91. Therefore, Sgce knock out (KO) models should approximate MD conditions both in vivo and in vitro. As there are no current treatments for MD, in sight into the pathology of the disease will aid in eventual treatments and help bring patients some relief by finally understanding their disease. Since a large percentage of MD patients are without the sgce protein, identifying what this protein’s function is and how its absence effects normal processing in the brain should help to identify the underlying cellular pathology which produces the MD phenotype. This research was performed under the hypothesis that, in neuronal cells, sgce interacts with a group of proteins that together play a role in stabilization and localization of ion channels and signaling proteins at the cell membrane. The aims were to: (1) Build a MD mouse model with either a conditional knock-out (cKO) or a conditional gene repair (cGR) mutation; (2) Use neuroblastoma cells to identify the other proteins which interact with sgce in neurons, and; (3) Determine if there is a disruption of the localization of the sgce-complex members due to the loss of sgce. Recombineering was used to complete the constructs for two transgenic mouse models: One model for the KO of exon 4 of sgce and one for the cGR in intron 1. Primary neurosphere lines from two previously generated chimeras were developed, as well as from a WT mouse. These neurosphere cell lines allowed comparisons of RT-PCR results from a heterogeneous neurological cell population to neuroblastoma cell lines. mRNA is present in neuronal cells for many of the DGC associated proteins. It was confirmed that the KD of sgce results in a reduction of nNOS protein and in increased proliferation of NIE cells. By using a nitrite/nitrate assay as well as studies with L-NAME, it was confirmed that this increased proliferation was in fact due to a lack of nNOS function. These proliferation changes did not occur in N2A cells, which do not express high levels of nNOS during proliferation, further confirming nNOS’s role in the proliferation changes. Using qRT-PCR, KD of sgce was shown to result in significant changes in the transcript levels for many DGC associated proteins. This suggests that a DGC-like complex is forming in neuronal cells. Also, as a result of difficulties with the research, it became clear that over-expression of sgce causes cell death. This observation was quantified using cell counts and TUNEL staining, both showing significant results. Additionally, several new constructs were created which will hopefully be of use for future students wanting to study sgce’s functions. New shRNA targeting sgce and sgcb have been made and both constructs result in reducing the expression of sgce. Seven different flag-tagged sgces have been created and some of these have been transferred into a tet-inducible system, which should circumvent the problem of over-expression. Finally GFP-tagged constructs for sgce and sgcb have been made and pooled clones have been developed. These tools will hopefully enable future students to continue to tease apart sgce’s function(s).

APA, Harvard, Vancouver, ISO, and other styles

16

Heaton, Daniel Anthony. "Role of nNOS in the autonomic control of cardiac excitability in cardiac physiological and pathophysiological states." Thesis, University of Oxford, 2005. http://ora.ox.ac.uk/objects/uuid:5dfc213d-7846-485d-93f1-1635a0018ef0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Coelho, Camila Henriques. "Análise da inibição da óxido nítrico sintase neuronal (nNOS) na liberação de vasopressina durante sepse experimental." Universidade de São Paulo, 2009. http://www.teses.usp.br/teses/disponiveis/60/60135/tde-30102009-022744/.

Full text

Abstract:

A fisiopatologia da sepse se caracteriza por hipotensão acompanhada de aumento da secreção de vasopressina (AVP) na fase inicial e diminuição numa fase mais tardia. Essa hipotensão é em parte devido ao aumento da quantidade de óxido nítrico, que juntamente com outros mediadores tem sua produção aumentada durante a sepse. A óxido nítrico sintase (NOS) é responsável pela síntese deste mediador, e sua isoforma neuronal (nNOS) está presente no músculo esquelético, pulmões, testículos, próstata, pele e também nos neurônios vasopressinérgicos do hipotálamo. O presente trabalho avaliou a participação do óxido nítrico produzido pela isoforma neuronal de NOS sobre a secreção temporal de AVP durante a sepse experimental. Ratos Wistar receberam injeção i.p. de 7-nitroindazol (50mg/kg ou 80mg/kg), inibidor específico da NOS neuronal, ou DMSO 10% + óleo de gergelim na proporção 1:9 (veículo) e após 30 minutos foram submetidos ao estímulo séptico por ligadura e perfuração cecal (CLP) ou à operação fictícia (OF). Em um grupo de animais, a sobrevida foi avaliada durante 5 dias. Em outro grupo, os animais foram decapitados 0, 4, 6, 18 e 24 horas após a cirurgia e o sangue processado para determinação do hematócrito, sódio sérico, osmolalidade, proteínas, glicose, creatinina, nitrato sérico e AVP plasmática. A neurohipófise foi removida para a determinação do conteúdo de AVP, e o hipotálamo dissecado para a determinação da atividade da NOS total. A mortalidade observada após CLP não foi modificada com o pré-tratamento com 7-NI (50mg/kg), assim como os aumentos temporais de hematócrito, glicose e nitrato sérico observados. As proteínas plasmáticas e o sódio sérico apresentaram diminuição após CLP e o pré-tratamento com 7-NI antecipou a perda proteica e postergou a diminuição do sódio sérico. Os animais após CLP não apresentaram alterações de creatinina e osmolalidade, entretanto quando prétratados com 7-NI, apresentaram aumento em 6 e 18 horas e diminuição a partir de 4hs, respectivamente. A atividade da NOS total no hipotálamo aumentou nos tempos determinados de 4 e 24 horas após CLP e este aumento foi reduzido com o prétratamento com o 7-NI nas doses de 50 e 80mg/kg, respectivamente. O conteúdo neurohipofisário de AVP diminuiu em 4, 6 e 18 horas após CLP e o pré-tratamento com 7-NI reduziu os estoques apenas em 0 e 6 horas. As concentrações plasmáticas de vasopressina apresentaram-se aumentadas sómente 6 horas após CLP e o pré-tratamento não alterou essas concentrações. Esses resultados permitem concluir que o NO produzido pela NOS neuronal não teria uma tarefa substancial na secreção de vasopressina durante sepse experimental.
The pathophysiology of sepsis is caracterized by hypotension accompanied by increase of vasopressin secretion (AVP) in early phase and decrease during late phase. This hypotension is due, in part, to the increase of nitric oxide (NO) production, that, like other mediators, shows high production during sepsis. Nitric oxide synthase (NOS) is responsible by synthesis of NO. The neuronal isoform of NOS is present in skeletic muscle, testicles, prostate, skin and vasopressinergics neurons of hypothalamus. The present work evaluated the participation of nitric oxide produced by neuronal NOS in temporal vasopressin secretion during experimental sepsis. Rats Wistar received intraperitoneal injection of 7-nitroindazole (50 or 80 mg/kg), an inhibitor of neuronal nitric oxide synthase activity, or DMSO 10% + sesame oil in the proportion 1:9 (vehicle) and after 30 minutes, they were submited to septic stimulus by cecal ligation and puncture (CLP) or to sham operation. In one of the groups, the survival rate was evaluated during 5 days. In other group, the animals were decapited 0, 4, 6, 18 and 24 hours after CLP and the blood was processed to determinate haematocrit, serum sodium, osmolality, proteins, glucose, creatinine, serum nitrate, and plasma AVP. Neurohypophysis was removed to determination of vasopressin content, and hypotalamus was dissected to determinate total NOS activity. Mortality observed after CLP was not affected by periferal injection of 7-nitroindazole (50 mg/kg) as well as haematocrit, glucose and nitrate increase. Serum sodium and plasma protein decreased after CLP and the treatment antecipated the loss protein, and delayed serum sodium decrease. CLP animals didn\'t show creatinine and osmolality alterations, but when treated with 7-nitroindazole, showed increase 6 and 18 hours, and decrease 4 hours, respectively. NOS activity in hypothalamus increased 4 and 24 hours after CLP, and was reduced with 7-NI pretreatment (50 and 80 mg/kg respectively). AVP neurohypophysis content diminished 4, 6 and 18 hours after CLP and 7-NI reduced the content just at 0 and 6 hours. Vasopressin plasma concentration increased just 6 hours after CLP and 7-NI pretreatment didn\'t alter this parameter. We concluded that NO produced by neuronal NOS doesn\'t have a substantial role in vasopressin secretion during experimental sepsis.

APA, Harvard, Vancouver, ISO, and other styles

18

Lewis, Sophronia. "The effect of ablation and acute inhibition of plasma membrane calcium ATPase 4 (PMCA4) with a novel inhibitor on isolated mouse mesenteric resistance arterial contractility." Thesis, University of Manchester, 2013. https://www.research.manchester.ac.uk/portal/en/theses/the-effect-of-ablation-and-acute-inhibition-of-plasma-membrane-calcium-atpase-4-pmca4-with-a-novel-inhibitor-on-isolated-mouse-mesenteric-resistance-arterial-contractility(676a26ea-867e-4947-9544-76b356fce23a).html.

Full text

Abstract:

Plasma membrane calcium ATPase 4 (PMCA4) is a calcium extrusion pump which may also modulate Ca2+-triggered signal transduction pathways. Previous studies postulate that PMCA4 modulates signalling via an interaction with neuronal nitric oxide synthase (nNOS) in localised plasmalemmal microdomains. The effect of PMCA4 on vascular contractility is unclear. This project has utilised PMCA4 ablated mice (PMCA4 KO (-/-)) and a novel specific PMCA4 inhibitor (termed AP2) to study the role of PMCA4 in mouse resistance artery contractility.Immunohistochemistry, Western blotting and polymerase chain reaction (PCR) confirmed the absence of PMCA4 in the brain, vasculature and ear snips obtained from PMCA4 KO (-/-) mice whereas it was present in those from wild type (WT (+/+)) mice. Pressure myography was employed to assesss contractile function of isolated, pressurised (to 60 mmHg) mesenteric resistance arteries from 3 months old male PMCA4 KO (-/-) and WT (+/+) mice, in response to high K+ physiological salt solution (KPSS) (40mM & 100mM) and noradrenaline (NA) (Log[NA] -9.0 to -5.0M). Passive lumen diameter and left and right wall thicknesses of arteries from PMAC4 KO (-/-) and WT (+/+) mice were taken at transmural pressures of 5-140 mmHg. Effects of acute PMCA4 inhibition with AP2 (10µM and 1µM), nitric oxide synthase (NOS) inhibition with LNNA (100µM) and specific nNOS inhibition with Vinyl-L-Nio (10µM) were also investigated. Effects of PMCA4 ablation and AP2 (10µM) on global intracellular Ca2+ changes ([Ca2+]i) in pressurised mesenteric arteries were assessed after loading arteries with the Ca2+-sensitive indicator indo-1. PMCA4 ablation had no effect on the magnitude of arterial constrictions or on the changes of [Ca2+]i in response to KPSS (40mM & 100mM) or to noradrenaline. The passive intra-lumen diameter, wall thickness, wall to lumen diameter and cross sectional area of mesenteric arteries across the intravascular pressure range studied were also not modulated by PMCA4 ablation. A leftwards shift in the stress to strain relationship and significant increase in beta elastic modulus (β) were revealed in arteries from PMCA4 KO (-/-) mice compared to those from WT (+/+) mice, suggesting that PMCA4 ablation reduces mesenteric arterial distensibility. Acute PMCA4 inhibition with AP2, significantly reduced arterial constrictions and the increase in [Ca2+]i in response to noradrenaline in arteries from WT (+/+) mice, but had no effect on arterial constrictions elicited by arteries from PMCA4 KO (-/-) mice. Inhibitory effects of AP2 were not present in arteries after NOS inhibition by LNNA and also after nNOS inhibition with Vinly-L-Nio. Hence, PMCA4 inhibition with AP2 reduces vascular constriction by a nNOS-dependent mechanism.In conclusion, the main findings of the study were that ablation and acute inhibition of PMCA4 with AP2 have different effects on mouse mesenteric resistance arterial contractility. This study provides more insight into PMCA4 as a significant modulator of signalling within the vasculature via effects on nNOS.

APA, Harvard, Vancouver, ISO, and other styles

19

Iyomasa, Daniela Mizusaki. "Avaliação dos efeitos do estresse crônico sob a ansiedade e a sensibilidade nociceptiva em ratos mantidos em ambiente enriquecido." Universidade de São Paulo, 2018. http://www.teses.usp.br/teses/disponiveis/59/59134/tde-24052018-222146/.

Full text

Abstract:

Respostas adaptativas ao estresse podem ser acompanhadas por alterações nos comportamentos emocionais, em particular relacionados com medo e ansiedade, bem como alterações na sensibilidade dolorosa. Ainda, tem sido investigado o papel do óxido nítrico em áreas encefálicas relacionadas ao comportamento defensivo. Embora várias evidências têm demonstrado que o enriquecimento ambiental promove melhora nos processos de memória, no aprendizado e em respostas nociceptivas, a relação entre o estresse crônico e as vantagens da utilização do enriquecimento ambiental ainda são pouco investigadas. O presente estudo teve como objetivo investigar se o enriquecimento ambiental promove alteração do comportamento emocional, da sensibilidade nociceptiva, bem como na imunorreatividade à nNOS no núcleo central da amígdala, na formação hipocampal e na região dorsolateral da substância cinzenta periaquedutal, em ratos submetidos ao estresse por isolamento social ou estresse crônico variado e mantidos em ambiente enriquecido ou sem enriquecimento. Ratos machos Wistar (~70g) foram divididos aleatoriamente em dois grandes grupos experimentais: Ambiente Padrão (Padrão) ou Ambiente Enriquecido (EE), mantidos por 38 dias. Cada grupo foi subdividido dependendo do tipo de estresse crônico: Controle (sem estresse), Isolamento Social (por 38 dias) e Estresse Crônico Variado (do dia 28 ao dia 37). Ao fim do tempo experimental (dia 38) os ratos foram avaliados quanto ao comportamento emocional pelos testes de labirinto em cruz elevado (LCE) e claro/escuro (TCE) e sensibilidade nociceptiva pelo teste da placa quente (a qual foi realizada em duas etapas, sendo a primeira medida no dia 0 e outra no dia 38). A eutanásia dos ratos ocorreu no dia 39, para coleta do encéfalo para análise da imunorreatividade à óxido nítrico sintase neuronal (nNOS). Levando-se em consideração o comportamento emocional e a sensibilidade nociceptiva, os diferentes tipos de estresse crônico diminuíram a porcentagem de tempo, a frequência de entrada e a exploração da extremidade dos braços abertos e na frequência de mergulho de cabeça no teste do LCE, apesar de não alterar a sensibilidade nociceptiva. Por outro lado, o enriquecimento ambiental aumentou a porcentagem de tempo, a frequência de entrada e a exploração da extremidade dos braços abertos no teste do LCE, apesar de não alterar a sensibilidade nociceptiva. Foi observado aumento da imunorreatividade à nNOS na formação hipocampal em diferentes tipos de estresse crônico. Em particular, na região de CA3 houve interação significante entre os fatores estresse por isolamento social e ambiente de manutenção. Deste modo, os resultados obtidos neste trabalho sugerem que a formação hipocampal desempenha importante função no efeito ansiogênico exercido pelos diferentes tipos de estressores crônicos (aqui representados pelo isolamento social e pelo estresse crônico variado) provavelmente pela ativação do sistema nitrérgico e sugere-se que o enriquecimento possa prevenir o comportamento do tipo ansioso.
Adaptive responses to stress may be accompanied by changes in emotional behaviors, in particular related to fear and anxiety, as well as changes in pain sensitivity. Furthermore, the role of nitric oxide in brain areas related to defensive behavior has been investigated. Although several evidences have shown that environmental enrichment improves memory processes, learning and nociceptive responses, the relationship between chronic stress and the advantages of using environmental enrichment is still poorly investigated. The present study aimed to investigate whether environmental enrichment promotes alteration of the emotional behavior, nociceptive sensitivity, as well as immunoreactivity to neuronal nitric oxide synthase (nNOS) in the central nucleus of the amygdala, hippocampal formation and dorsolateral periaqueductal gray matter in rats submitted to social isolation stress or chronic unpredictable stress and reared in enriched environment or standard environment. Male Wistar rats (~ 70g) were randomly divided into two major experimental groups: Standard Environment (Standard) or Enriched Environment (EE), maintained for 38 days. Each group was subdivided according to the type of chronic stress: Control (without stress), Social Isolation (for 38 days) and Chronic Unpredictable Stress (from day 28 to day 37). At the end of the experimental time (day 38), the rats were evaluated for emotional behavior by elevated plus maze (EPM) and light/dark box (LDBT) tests and nociceptive sensitivity by the hot plate test (which was performed in two steps , the first being measured on day 0 and the other on day 38). Euthanasia of rats occurred on day 39, to collect the brain for nNOS immunoreactivity analysis. Taking into account emotional behavior and nociceptive sensitivity, the different types of chronic stress decreased the percentage of time, the frequency of entry of the open arms, end-arm exploration and the head dipping frequency in the EPM, despite of not altering the nociceptive sensitivity. On the other hand, environmental enrichment increased the percentage of time, the frequency of entry of the open arms and the end arm-exploration in the EPM test, although it did not alter the nociceptive sensitivity. Increased immunoreactivity to nNOS in hippocampal formation was observed in different types of chronic stress. In particular, in the CA3 region there was a significant interaction between stress factors due to social isolation and maintenance environment. Thus, the results obtained in this study suggest that hippocampal formation plays an important role in the anxiogenic effect exerted by the different types of chronic stressors (represented here by social isolation and by chronic chronic stress) probably due to the activation of the nitrergic system and it is suggested that environmental enrichment can prevent of anxiety-like behavior.

APA, Harvard, Vancouver, ISO, and other styles

20

Bird, Diane Carol. "An investigation into the role of neuronal nitric oxide synthase (nNOS) in the phencyclidine mouse model of schizophrenia." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2000. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape4/PQDD_0015/MQ57249.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Hirsch, Tamara. "A behavioural evaluation of the potential of nNOS inhibitors to control dyskinesia in animal models of Parkinson's disease." Thesis, King's College London (University of London), 2012. https://kclpure.kcl.ac.uk/portal/en/theses/a-behavioural-evaluation-of-the-potential-of-nnos-inhibitors-to-control-dyskinesia-in-animal-models-of-parkinsons-disease(777432ce-93ec-429c-a5c8-41d42dd2069b).html.

Full text

Abstract:

Long-term dopaminergic therapy in Parkinson’s disease (PD) can lead to motor complications including dyskinesia which can be treated with amantadine, an N-methyl-D-aspartate (NMDA) receptor antagonist. NMDA receptor activation is linked with nitric oxide (NO) production and changes in synaptic plasticity, suggesting a role in dyskinesia. This led to the hypothesis that NO, produced by neuronal nitric oxide synthase (nNOS), contributes to the occurrence and evolution of dyskinesia in PD. Therefore, these studies investigated the effects of nNOS inhibition, using the nNOS inhibitors ARR17477 and 7-nitroindazole (7-NI), on the dyskinesia expression and priming processes in rodent and primate models of PD following L-dopa and dopamine agonist treatment. To explore the role of nNOS inhibition on established dyskinesia, 6-OHDA-lesioned rats, primed to exhibit stable abnormal involuntary movements (AIMs), the rodent analogue of dyskinesia, were acutely challenged with nNOS inhibitors plus L-dopa or ropinirole. No reduction in AIMs was observed following nNOS inhibition. In order to investigate the potential for nNOS inhibitors to reduce the priming for AIMs, naïve 6-OHDA-lesioned rats were treated chronically with ARR17477 or 7-NI plus either L-dopa or ropinirole. Again, there was no beneficial effect of nNOS inhibition on the emergence of L-dopa- or ropinirole-induced AIMs. nNOS inhibition was also investigated in MPTP-treated primates, the gold standard behavioural model of PD. ARR17477 did not reduce the expression of established dyskinesia following L-dopa or ropinirole treatment. Similarly nNOS inhibition did not attenuate L-dopa-induced priming for dyskinesia in this model. In conclusion, inhibition of nNOS in 6-OHDA-lesioned rats and MPTP-treated primates did not reduce the expression or priming of L-dopa- or ropinirole-induced dyskinesia. These findings do not support a role for nitric oxide in processes underlying dyskinesia and suggest that nNOS inhibitors would not be beneficial in either preventing or attenuating motor complications in PD patients.

APA, Harvard, Vancouver, ISO, and other styles

22

Denadai, Magda Aline. "Efeitos do 7-nitroindazole, um inibidor da sintase neuronal do oxido nitrico (nNOS), sobre o condiciomaneto contextural em pombos." [s.n.], 2008. http://repositorio.unicamp.br/jspui/handle/REPOSIP/314745.

Full text

Abstract:

Orientador: Elenice Aparecida de Moraes Ferrari
Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia
Made available in DSpace on 2018-08-11T20:16:54Z (GMT). No. of bitstreams: 1 Denadai_MagdaAline_M.pdf: 823511 bytes, checksum: 1887972f9e5047fecbd7195247b586a8 (MD5) Previous issue date: 2008
Resumo: O óxido nítrico (NO), um neurotransmissor não convencional, tem papel importante em processos neurobiológicos de comportamento e de memória. Sua síntese é mediada por três isoformas de sintase do óxido nítrico (NOS): a neuronal (nNOS), a endotelial (eNOS) e induzível (iNOS). Este trabalho analisou o efeito do 7-nitroindazole (7-NI), um inibidor seletivo da nNOS, no condicionamento clássico aversivo em pombos. Foram usados 4 grupos: tratados com 7-NI (grupo 7-nitroindazole; G7-NI, n=5), tratados com óleo de amendoim (grupo veículo; GV, n=5), controle/sem tratamento (grupo controle; GC, n=5) e grupo não tratado/não condicionado (grupo manipulação; GM, n=5). A administração i.p. de 7-NI (25 mg/kg), ou do óleo de amendoim foi feita imediatamente após o treinamento. O G7-NI, o GV e o GC receberam três associações som-choque (5°, 10° e 15º minutos) numa sessão de 20 min. O teste a o contexto foi realizado 24 horas depois. As sessões foram gravadas para posterior transcrição e análise comportamental. A ocorrência da resposta de congelamento durante o treino não diferiu entre os grupos (p>0,05), mas durante o teste foi menor para o G7-NI em comparação ao treino (p<0.01) e aos demais grupos no teste (p<0.001). A atividade da NOS dependente de Ca++ no hipocampo foi menor no G7-NI do que nos outros grupos (p<0,01). Análise por Western blot indicou aumento na expressão de nNOS no G7-NI (p<0,05). A administração sistêmica de 7-NI teve um efeito amnésico sobre a memória contextual aversiva, indicando que a atividade da NOS dependente de Ca++ é importante para os processos de condicionamento clássico aversivo em pombos.
Abstract: Nitric oxide (NO) is an unsual neurotransmitter that plays an important role in neurobiological functions underlying behavior and memory. NO synthesis and release can be mediated by three isoforms of NO synthases (NOS): neuronal (nNOS), endothelial (eNOS) and inducible (iNOS). This study examined the effect of 7-nitroindazole (7-NI), a selective nNOS inhibitor, on contextual fear conditioning in pigeons. Four groups of pigeons were used: treated with 7-NI (7-NI; n=5), treated with peanut oil (Vehicle; n=5), non treated controls (Control; n=5) and non treated and no-trained controls (Non-trained; n=5). Treatment consisted in 7-NI (25 mg/kg; i.p.) or vehicle (peanut oil) administration, immediately after training. All the animals were trained in one 20 min session during which three tone-shock pairings (5th, 10th and 15th minutes) were presented. The test to the context was conducted 24h later. Behavioral categories were analyzed through the transcription of video-tapes of the sessions. The groups 7-NI, Vehicle and Control showed no significant differences in freezing during the conditioning session (p>0.05). During the test to the context the group 7-NI expressed significantly lower freezing as compared to Vehicle and Control (p<0.05). The 7-NI pigeons showed lower hippocampal activity of Ca++ dependent-NOS than Vehicle and Control groups (p<0.01). Western blot analysis indicated significant increase in nNOS expression (p<0.05). The systemic administration of 7-NI induced amnestic effects on contextual fear memory that evidence that Ca++-dependent NOS activity is required for fear conditioning in pigeons.
Mestrado
Fisiologia
Mestre em Biologia Funcional e Molecular

APA, Harvard, Vancouver, ISO, and other styles

23

Eskandari, Julia Mirjam [Verfasser], Viktoria [Akademischer Betreuer] Kolb-Bachofen, Daniela [Akademischer Betreuer] Bruch-Gerharz, and Ulrich [Akademischer Betreuer] Germing. "Untersuchungen zur nNOS an psoriatischer Haut / Julia Mirjam Eskandari. Gutachter: Daniela Bruch-Gerharz ; Ulrich Germing. Betreuer: Viktoria Kolb-Bachofen." Düsseldorf : Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf, 2011. http://d-nb.info/1018272518/34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Schonhoff, Christopher M. "The Regulation of nNOS During Neuronal Differentiation and the Effect of Nitric Oxide on Hdm2-p53 Binding: a Dissertation." eScholarship@UMMS, 2000. https://escholarship.umassmed.edu/gsbs_diss/57.

Full text

Abstract:

Nitric oxide is a ubiquitous signaling molecule with both physiological and pathological functions in biological systems. Formed by the enzymatic conversion of arginine to citrulline, NO, has known roles in circulatory, immune and nervous tissues. In the nervous system nitric oxide has been implicated in long-term potentiation, neurotransmitter release, channel function, neuronal protection and neuronal degeneration. Much of our work has focused on yet another role for nitric oxide in cells, namely, neuronal differentiation. During development, neuronal differentiation is closely coupled with cessation of proliferation. We use nerve growth factor (NGF)-induced differentiation of PC12 pheochromocytoma cells as a model and find a novel signal transduction pathway that blocks cell proliferation. Treatment of PC12 cells with NGF leads to induction of nitric oxide synthase (NOS). The resulting nitric oxide (NO) acts as a second messenger, activating the p21(WAF1) promoter and inducing expression of p21(WAF1) cyclin-dependent kinase inhibitor. NO activates the p21(WAF1) promoter by p53-dependent and p53-independent mechanisms. Blocking production of NO with an inhibitor of NOS reduces accumulation of p53, activation of the p21(WAF1) promoter, expression of neuronal markers, and neurite extension. To deternine whether p21(WAF1) is required for neurite extension, we prepared a PC12 line with an inducible p21(WAF1) expression vector. Blocking NOS with an inhibitor decreases neurite extension, but induction of p21(WAF1) with isopropyl-1-thio-beta-D-galactopyranoside restored this response. Levels of p21(WAF1) induced by isopropyl-1-thio-beta-D-galactopyranoside were similar to those induced by NGF. Therefore, we have identified a signal transduction pathway that is activated by NGF; proceeds through NOS, p53 and p21(WAF1) to block cell proliferation; and is required for neuronal differentiation by PC12 cells. In further studies of this pathway, we have examined the role of MAP kinase pathways in neuronal nitric oxide synthase (nNOS) induction during the differentiation of PC12 cells. In NGF-treated PC12 cells, we find that nNOS is induced at RNA and protein levels, resulting in increased NOS activity. We note that neither nNOS mRNA, nNOS protein nor NOS activity is induced by NGF treatment in cells that have been infected with a dominant negative Ras adenovirus. We have also used drugs that block MAP kinase pathways and assessed their ability to inhibit nNOS induction. Even though U0126 and PD98059 are both MEK inhibitors, we find that U0126, but not PD98059, blocks nNOS induction and NOS activity in NGF-treated PC12 cells. Also, the p38 kinase inhibitor, SB 203580, does not block nNOS induction in our clone of PC12 cells. Since the JNK pathway is not activated in NGF-treated PC12 cells, we determine that the Ras-ERK pathway and not the p38 or JNK pathway is required for nNOS induction in NGF-treated PC12 cells. We find that U0l26 is much more effective than PD98059 in blocking the Ras-ERK pathway, thereby explaining the discrepancy in nNOS inhibition. We conclude that the Ras-ERK pathway is required for nNOS induction. The activation of soluble guanylate cyclase and the production of cyclic GMP is one of the best characterized modes of NO action. Having shown that inhibition of NOS blocks PC12 cell differentiation we tested whether nitric oxide acts through soluble guanylate cyclase to lead to cell cycle arrest and neuronal differentiation. Unlike NOS inhibition, the inhibition of soluble guanylate cylcase does not block the induction of neuronal markers. Moreover, treatment of NGF-treated, NOS-inhibited PC12 cells with a soluble analog of cyclic GMP was unable to restore differentiation of those cells. Hence, cGMP is not a component of this pathway and we had to consider other mechanisms of NO action. It has become increasingly evident that another manner by which NO may exert its effects is by S-nitrosylation of cysteine residues. We tested, in vitro whether nitric oxide may control p53 by S-nitrosylation and inactivation of the p53 negative regulator, Hdm2. Treatment of Hdm2 with a nitric oxide donor inhibits Hdm2-p53 binding, the first step in Hdm2 regulation of p53. The presence of cysteine or DTT blocks this inhibition of binding. Moreover, nitric oxide inhibition of Hdm2-p53 binding was found to be reversible. Sulfhydryl-sensitivity and reversibility are consistent with nitrosylation. Finally, we have identified a critical cysteine residue that nitric oxide modifies in order to disrupt Hdm2-p53 binding. Mutation of this residue from a cysteine to an alanine does not interfere with binding but rather eliminates the sensitivity of Hdm2 to nitric oxide inactivation.

APA, Harvard, Vancouver, ISO, and other styles

25

Kececioglu, Ekin. "Analysis Of Immunoreactivity Of Nos Isoforms (nnos, Enos, Inos) In Hippocampus Of Young Rats Classified As Good And Poor Learners." Master's thesis, METU, 2012. http://etd.lib.metu.edu.tr/upload/12614994/index.pdf.

Full text

Abstract:

Despite very extensive studies on molecular mechanisms of learning and memory formation it is little known about individual variation in the learning skills within a random animal population and about the differences in the brain biochemistry behind this variation. In the present study, we have focused on the expression and distribution of nitric oxide synthase (NOS), one of the molecules implemented in activity-dependent neuroplasticity, in the rat hippocampus, the structure critical for episodic memory in humans and animals. The aim of the present study was to investigate the differences in expression of three different NOS isoforms: neural (n), epithelial (e), and inducible (i), in four hippocampal subregions (CA1, CA3, DG, and hilus) between Wistar rats classified on the basis of their performance in partially baited 12-arm radial maze as &ldquo
good&rdquo
and &ldquo
poor&rdquo
learners. The NOS isoforms were visualized on coronal hippocampal sections using fluorescent immunohistochemistry technique and n- and eNOS images were processed using ImageJ software, while iNOS immunoreactivity (IR) was assessed by counting immunoreactive cells. In this study, overall hippocampal levels of nNOS were significantly higher than those of eNOS and iNOS. The level of n and eNOS was higher in CA1 compared to DG/hilus areas, but lower than that in CA3 region. The expression of iNOS was the highest in CA1 and the lowest in hilus region. nNOS IR was significantly higher in &ldquo
poor&rdquo
than in &ldquo
good&rdquo
learners but only in CA1 region. No significant between-group differences were found in eNOS expression. iNOS expression was higher in &ldquo
poor&rdquo
learners but it did not reach the required significance level.

APA, Harvard, Vancouver, ISO, and other styles

26

Barua, Anupama. "The role of neuronal nitric oxide synthase (nNOS) in ischaemia/reoxygenation-induced injury and in protection of the mammalian myocardium." Thesis, University of Leicester, 2010. http://hdl.handle.net/2381/8754.

Full text

Abstract:

Background: In physiological condition, NO is produced by two constitutive NOS isoform; eNOS and nNOS. Both isoforms have specific cellular locations and although the role of eNOS in myocardial ischaemic injury and in cardioprotection has been thoroughly addressed, but the role of nNOS remains unclear. Therefore, the aims of the thesis were to: (i) investigate the role of nNOS in ischaemia/reoxygenation-induced injury, (ii) determine whether its effect is species-dependent, (iii) elucidate the relationship of nNOS with mitoKATP channels and p38MAPK, two key components of IP and (iv) investigate whether modulation of the NO metabolism can overcome the unresponsiveness of the diabetic myocardium to IP. Methods and Results: Ventricular myocardial slices from rats and mice, nNOS knockout mice, and also from human right atrial slices were subjected to 90min ischaemia and 120min reoxygenation (37°C). Muscles were randomized to receive various treatments. Both the provision of exogenous NO and the inhibition of endogenous NO production significantly reduced tissue injury (creatine kinase release, cell necrosis and apoptosis), an effect that was species–independent. The protection seen with nNOS inhibition was as potent as that of IP, however, in nNOS-knocked out mice the cardioprotective effect of non-selective NOS (L-NAME) and selective nNOS inhibition (TRIM) and also that of IP was blocked while the benefit of exogenous NO remained intact. Additional studies revealed that the cardioprotection afforded by of exogenous NO and by inhibition of nNOS were unaffected by the mitoKATP channel blocker 5-HD although it was abrogated by p38MAPK blocker SB203580. Finally, in diabetic myocardium, IP did not decrease CK release neither reduced cell necrosis or apoptosis. In diabetic myocardium NO donor SNAP, inhibitor L-NAME and TRIM significantly reduced CK leakage, cell necrosis and apoptosis. Conclusions: nNOS plays a dual role in ischaemia/reoxygenation on that its presence is necessary to afford cardioprotection by IP but its inhibition reduces myocardial ischaemic injury. The role of nNOS is species-independent and exerted downstream of the mitoKATP channels and upstream of p38MAPK. Moreover, both the provision of exogenous NO and the suppression of endogenous NO production resulted in potent protection of diabetic human myocardium, overcoming the unresponsiveness of these tissues to IP.

APA, Harvard, Vancouver, ISO, and other styles

27

Pereira, Linus de Queiroz. "Silenciamento da expressão da enzima óxido nítrico sintase neuronal (nNOS) em linhagem de neuroblastoma via siRNAs sintéticos em dupla fita." reponame:Repositório Institucional da UnB, 2011. http://repositorio.unb.br/handle/10482/20854.

Full text

Abstract:

Dissertação (mestrado)—Universidade de Brasília, Faculdade de Agronomia e Medicina Veterinária, Programa de Pós-Graduação em Saúde Animal, 2011.
Submitted by Fernanda Percia França (fernandafranca@bce.unb.br) on 2016-06-13T18:51:41Z No. of bitstreams: 1 2011_LinusQueirozPereira.pdf: 2001961 bytes, checksum: 8c777bf26af4a287663fdc2c8e5aa829 (MD5)
Approved for entry into archive by Patrícia Nunes da Silva(patricia@bce.unb.br) on 2016-07-03T21:36:07Z (GMT) No. of bitstreams: 1 2011_LinusQueirozPereira.pdf: 2001961 bytes, checksum: 8c777bf26af4a287663fdc2c8e5aa829 (MD5)
Made available in DSpace on 2016-07-03T21:36:07Z (GMT). No. of bitstreams: 1 2011_LinusQueirozPereira.pdf: 2001961 bytes, checksum: 8c777bf26af4a287663fdc2c8e5aa829 (MD5)
O óxido nítrico (NO) é formado pelas enzimas NO sintases e desempenha papel na patogênese da neurodegeneração. NO sintase neuronais são expressas em áreas cerebrais lesionadas e sua inibição reduz efeitos de agentes neurotóxicos. O atual estudo desenvolveu siRNAs (small interfering RNAs) direcionados a duas sequências do RNAm de nNOS, presentes nos exons 2 e 28. Primeiramente, foi utilizado o algoritmo Biopredsi para identificar alvos de RNAi. Foi realizada síntese química dos siRNA duplos com 21 nucleotídeos - exon2_hnNOS e exon28hnNOS (Qiagen). Células de neuroblastomas SH-SY5Y receberam 150 pmol ou 300 pmol de cada siRNA estruturado em lipossomas (Lipofectamine 2000®, Invitrogen). Utilizou-se o controle negativo scramble All-Stars® (Qiagen). Os meios de cultivo celular utilizados foram Optimen® e DMEM® (Gibco), pelas primeiras 6h e para as 24h de incubação restantes, respectivamente. O conteúdo de RNAm de nNOS foi quantificado por PCR em tempo real via SYBR Green®; os efeitos de silenciamento foram apresentados pela expressão relativa (2-ΔΔCT). O nível de RNAm foi reduzido para até 60% do controle; os efeitos de silenciamento variaram de acordo com os alvos e doses. Os efeitos dos siRNA sobre a apoptose por neomicina foram determinados pelo ensaio de MTT. As células foram lesionadas por neomicina e tratadas com um dos siRNAs (exon2_hnNOS, exon28hnNOS ou scramble) por dois tempos distintos: imediatamente após ou 24h após a lesão. Ambas estruturas de siRNA mostraram efeitos antiapoptóticos, que alcançaram o máximo de 28,7%. Os efeitos variaram de acordo com o siRNA e o tempo de tratamento. Exon2_hnNOS produziu o maior efeito quando o tratamento foi realizado logo após lesão; exon28_hnNOS foi mais efetivo 24h após a lesão. Os resultados do atual estudo mostram a utilidade de siRNAs no entendimento da patogenia de doenças neurológicas e abrem novos caminhos para a terapia gênica de doenças neurodegenerativas.
Nitric oxide (NO) is formed by the NO synthase enzymes and play pivotal roles in the pathogenesis of neurodegenerative diseases. Neuronal NO synthase enzyme (nNOS) is expressed in brain areas submitted to injury, and its pharmacological blocking can decrease the effects of neurotoxic agents. In our study, we developed and tested two siRNAs targeted to two different nNOS mRNA sequences, located in the exons 2 and 28. Firstly, we used the Biopredsi algorithm to identify the RNAi targets. The synthetic siRNA duplexes with 21 nucleotides (exon2_hnNOS and exon28_hnNOS) were synthetized by Qiagen. Neuroblastoma cells SH-SY5Y received 150 pmol or 300 pmol of each siRNA mixed with Lipofectamine 2000® (Invitrogen). The negative control was the commercial scramble All-Stars® (Qiagen). The cell culture media used in this study were Optimen® and DMEM® (Gibco), for the first 6h and for the remaining 24h of incubation, respectively. The mRNA content was quantified by reverse transcription real-time PCR with SYBR Green® and the silencing effects on nNOS expressed by the relative expression (2-ΔΔCT). The nNOS mRNA content was reduced to 60% to the control level; the silencing effects varied according to the targets and doses used. To determine the effects of siRNA on the apoptotic phenotype, we used the MTT assay. Cells were lesioned by neomycin and treated with each of the siRNAs (exon2_hnNOS, exon28_hnNOS, or scramble) at two time-points: immediately after – or 24h after lesion. Both siRNA structures showed anti-apoptotic effects that reached 28.7%. The effects varied according to the siRNA used and the treatment time-point. Exon2_hnNOS produced the highest effect when the treatment began immediately after lesion; exon28_hnNOS was more effective 24h after lesion. Our results encourage the use of siRNAs to study the role of nNOS in the pathogenesis of brain diseases and highlighted a new therapeutic aproach for neurodegenerative diseases.

APA, Harvard, Vancouver, ISO, and other styles

28

Balda, Mara A. "Ontogeny- and Sex-Dependent Contributions of the Neuronal Nitric Oxide Synthase (nNOS) Gene to Rewarding and Psychomotor Stimulating Effects of Cocaine." Scholarly Repository, 2009. http://scholarlyrepository.miami.edu/oa_dissertations/257.

Full text

Abstract:

Multiple interactions between dopamine (DA), glutamate, and nitric oxide (NO) in mesolimbic and corticostriatal circuits suggest that NO may play a critical role in cocaine-induced behavioral and neural plasticity. Clinical and preclinical studies have revealed that females and adolescents display unique vulnerabilities to the behavioral and neurochemical effects of cocaine as a result of sex-dependent and ontogeny-dependent differences in dopaminergic systems. Thus, my research objectives were to investigate the contributions of the neuronal nitric oxide synthase (nNOS) gene, ontogeny, and gender on the rewarding and sensitizing effects of cocaine. I found that nNOS significantly influences the rewarding aspects of cocaine in adolescent mice and adult male mice (i.e., major deficits in several phases of cocaine conditioned place preference (CPP) were detected in nNOS knockout (KO) adolescent mice and nNOS KO adult male mice). However, the contribution of nNOS was sex-dependent as CPP phases were normal in KO adult females. In contrast to CPP, I found a major ontogeny-dependent contribution of nNOS to the sensitizing effects of cocaine. Namely, while nNOS is essential for the development of behavioral sensitization in adult males, this type of behavioral plasticity develops independently of nNOS during adolescence. The contribution of nNOS was once again sex-dependent as behavioral sensitization was normal in adult KO females. Together, this line of investigation has revealed that the NO-signaling pathway has a) a sex-dependent role in the neuroplasticity underlying cocaine CPP and b) a sex-dependent and ontogeny-dependent influence on cocaine-induced behavioral sensitization. Stereological and western blot analysis revealed that a sensitizing regimen of cocaine resulted in an increase in nNOS and tyrosine hydroxylase (TH) immunoreactivity in the dorsal striatum (dST) of adult, but not adolescent, wild-type (WT) male mice. In the absence of nNOS, dopaminergic neurons in the ventral tegmental area (VTA) were severely reduced and cocaine caused a downregulation of dST TH suggesting that nitrergic levels modulate TH. Thus, the finding that nNOS is essential for the development of sensitization in adulthood, but not adolescence, together with the fact that cocaine upregulated nNOS and TH in the dST in adult, but not adolescent mice, strongly suggest that the nitrergic system underlies behavioral sensitization through modulation of the dopaminergic system in adulthood. These findings suggest different approaches in the clinical treatment of drug craving and drug-seeking behavior in adolescent and adult patients.

APA, Harvard, Vancouver, ISO, and other styles

29

Lustosa, Cátia Valderês dos Santos Faria. "Interferência de RNA para silenciamento gênico da enzima NO sintase neuronal (nNOS) no modelo in vitro de neurodegeneração por interferon gama." reponame:Repositório Institucional da UnB, 2013. http://repositorio.unb.br/handle/10482/13967.

Full text

Abstract:

Dissertação (mestrado)—Universidade de Brasília, Faculdade de Ciências da Saúde, Programa de Pós-Graduação em Ciências da Saúde, 2013.
Submitted by Tania Milca Carvalho Malheiros (tania@bce.unb.br) on 2013-07-29T13:08:16Z No. of bitstreams: 1 2013_CatiaValderesSantosFariaLustosa_Parcial.pdf: 3115952 bytes, checksum: 57e3839be1f01cc4531234cdbb46186a (MD5)
Rejected by Guimaraes Jacqueline(jacqueline.guimaraes@bce.unb.br), reason: Tânia, Por favor, trocar o arquivo. Obrigada! Jacqueline on 2013-08-01T15:58:31Z (GMT)
Submitted by Tania Milca Carvalho Malheiros (tania@bce.unb.br) on 2013-08-06T13:44:14Z No. of bitstreams: 1 2013_CatiaValderesSantosFariaLustosa_Parcial.pdf: 3117212 bytes, checksum: b27339620776f31f8a6030cb8dbf3488 (MD5)
Approved for entry into archive by Guimaraes Jacqueline(jacqueline.guimaraes@bce.unb.br) on 2013-08-16T14:33:33Z (GMT) No. of bitstreams: 1 2013_CatiaValderesSantosFariaLustosa_Parcial.pdf: 3117212 bytes, checksum: b27339620776f31f8a6030cb8dbf3488 (MD5)
Made available in DSpace on 2013-08-16T14:33:33Z (GMT). No. of bitstreams: 1 2013_CatiaValderesSantosFariaLustosa_Parcial.pdf: 3117212 bytes, checksum: b27339620776f31f8a6030cb8dbf3488 (MD5)
A vulnerabilidade de neurônios dopaminérgicos a insultos químicos continua sendo uma questão relevante na neuropatologia. Estudos anteriores revelam aumento dos níveis de interferon gama (IFN- ) e da enzima óxido nítrico sintase neuronal (nNOS) durante a injúria de células neuronais. Entretanto, até o momento, nenhum trabalho avaliou se a nNOS afeta a viabilidade de neurônios dopaminérgicos expostos ao IFN- . Para avaliar o papel da nNOS nas respostas celulares ao IFN- , o presente estudo realizou silenciamento gênico da enzima nNOS via interferência de RNA (RNAi) no modelo de neurodegeneração de células SH-SY5Y. Primeiro, analisou-se o conteúdo de RNAm de nNOS através de PCR em tempo real. Três RNAs interferentes sintéticos curtos foram testados nos tempos de 8h e 24h, em doses de 18,75nM e 37,5nM. Testou-se também um vetor de expressão de grampos curtos de RNA, denominado pnNOS_hum_4400 para o silenciamento da enzima. Os efeitos do silenciamento de nNOS sobre a viabilidade das células SH-SY5Y lesadas foram medidas via ensaio de 3-(4,5)-dimethylthiazol-2-y1)-2,5-diphenyltetrazolium bromide (MTT). O melhor efeito de silenciamento de nNOS ocorreu no tempo de 24h pós-transfecção para siRNAnNOShum_3987 e siRNAnNOShum_4400, com diminuição de 0,46 e 0,66 vezes. SiRNAnNOShum_4400 e o vetor pnNOS_hum_4400 aumentaram a viabilidade das células lesadas por IFN-y em 5,0 % e 15,8%, respectivamente. Conclui-se que a enzima nNOS participa de eventos celulares ligados à injúria de células SH-SY5Y causada pelo IFN- y. ______________________________________________________________________________ ABSTRACT
The vulnerability of dopaminergic neurons to chemical insults remains a relevant issue in neuropathology. Previous studies found increased levels of interferon gamma (IFN- ) and the neuronal nitric oxide synthase enzyme (nNOS) during neuronal injury. No previous work, however, has evaluated whether nNOS affects the viability of dopaminergic neurons exposed to IFN- . To gain more insight into the role of nNOS in cell responses to IFN- , the present study carried out the enzyme gene silencing by RNA interference (RNAi) in the neuron-like SH-SY5Y model of neurodegeneration. We first analyzed the nNOS mRNA knocking down by using a reverse transcription real-time quantitative polymerase chain reaction (RT-qPCR). Three small interfering RNAs were tested at 8h and 24h in doses of 18.75nM and 37.5nM. We also tested a short-hairpin RNA expression vector named pnNOS_hum_4400 to improve enzyme knocking-down. nNOS silencing effects on the viability of injured SH-SY5Y cells were measured by the 3-(4,5)-dimethylthiazol-2-y1)-2,5-diphenyltetrazolium bromide (MTT) assay. The highest knocking down in nNOS mRNA content occurred at 24h post-transfection for siRNAnNOShum_3987 and siRNAnNOShum_4400, with 0.46 and 0.66 fold decrease. SiRNAnNOShum_4400 and the vector pnNOS_hum_4400 ameliorate the viability of cells injured by IFN- 5,0 % 15,8 % ely. We concluded that nNOS enzyme plays at least a partial role in SH-SY5Y cell degeneration caused by IFN-y .

APA, Harvard, Vancouver, ISO, and other styles

30

Silva, Maria Isabel. "Distribuição de celulas imunorreativas para sintase neuronal do oxido nitrico (nNOS) no hipocampo de pombos (Columba livia) apos aprendizagem de escolha alimentar." [s.n.], 2007. http://repositorio.unicamp.br/jspui/handle/REPOSIP/314142.

Full text

Abstract:

Orientadores: Elenice Aparecida de Moraes Ferrari, Claudio Antonio Barbosa de Toledo
Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia
Made available in DSpace on 2018-08-10T10:38:58Z (GMT). No. of bitstreams: 1 Silva_MariaIsabel_M.pdf: 1381550 bytes, checksum: 9cb336aef794086ff363f071f8040818 (MD5) Previous issue date: 2007
Resumo: O hipocampo exerce papel fundamental no processamento de aprendizagem e memória espaciais. Comparações das características funcionais, anatômicas e neuroquímicas do hipocampo são favorecidas por evidência oriunda de estudo sobre aprendizagem especial em mamíferos e aves. O objetivo do presente estudo foi analisar a marcação imunohistoquímica de células nNOS- positivas no hipocampo de pombos (C. lívia) após diferentes duração do treino em aprendizagem especial. Foram analisados grupos de animais não treinados (MAN), treinados em 1 sessão (EXP1), treinados em 5 sessões (EXP5), exposto à arena em 1 sessão (CONT1) ou em 5 sessões (CONT5). As sessões foram realizadas numa arena onde havia quatro comedouros, um dos quais com alimento. Em cada sessão, com seis tentativas, registrou-se a latência (seg) e a assertividade da escolha de um comedouro. Após os testes comportamentais, usou-se imunoistoquímica para a análise da marcação de células nNOS-positiva no hipocampo dorsal e ventral. O grupo EXP5 teve diminuição da latência de escolha ('F IND. 4,28¿= 23,74; p < 0,001) e aumento das respostas corretas ('F IND. 4,35¿= 8,66; p < 0,001) em função do treino. A marcação das células nNOS-positivas no hipocampo foi significativamente maior no hipocampo dorsal dos animais EXP5 em comparação com o hipocampo ventral ('F IND. 4,22¿= 104,79; p<0,001) e com os demais grupos ('F IND. 4,22¿= 10,17; p < 0,001). O aumento da imunorratividade de células nNOS- positivas no hipocampo dorsal de pombos após a aprendizagem da localização do comedouro correto sugere o envolvimento desta região e de processos mediados pro transmissão glutamatérgica nesse processo de aprendizagem e memória em pombos
Abstract: The hippocampus has fundamental role in spatial learning and memory processes. Functional and neurochemical analysis of the hippocampus are favored by evidence on spatial learning in mammals and birds. The present study examined the immunohistochemical expression of nNOS-positive cells in the hippocampus of pigeons (C. livia) after training in food location task. Animals were trained in one (EXP1) or five (EXP5) sessions or had one (CONT1) or five sessions (CONT5) of exposure to the experimental arena. The six trials sessions were conducted daily in one arena with 4 food bowls, one of which had food. Latency and accuracy of choise recorded. After behavioral tests, nNOS immunoractivity in hippocampal cells was analyzed. EXP 5 showed reduction imunoreactivity in hippocampal cells was analysed. EXP5 showed reduction in latency of choise ('F IND. 4,28¿= 23,74; p < 0,001) and increassis in correct choise ('F IND. 4,35¿= 8,66; p < 0,001) as function of the training. The expression of nNOS- positive cells was significantily higher in the dorsal hippocampus of EXP5 group as compared with the ventral hippocampus ('F IND. 4,22¿= 104,79; p < 0,001) and the other groups ('F IND. 4,28¿= 10,17; p < 0,001). The increases of nNOS immunoreactive neurons after learning of the food location suggest that nNOS is involved in processes of spatial learning and memory that are mediated by the dorsal hippocampus of pigeons
Mestrado
Fisiologia
Mestre em Biologia Funcional e Molecular

APA, Harvard, Vancouver, ISO, and other styles

31

Machado, Aline Vilar da Silva. "Variação circadiana da expressão da sintase neuronal de óxido nítrico (nNOS) no hipocampo e o condicionamento contextual aversivo em pombos (Columba livia)." [s.n.], 2011. http://repositorio.unicamp.br/jspui/handle/REPOSIP/314744.

Full text

Abstract:

Orientador: Elenice Aparecida de Moraes Ferrari
Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia
Made available in DSpace on 2018-08-18T00:49:19Z (GMT). No. of bitstreams: 1 Machado_AlineVilardaSilva_M.pdf: 2487506 bytes, checksum: ec15fc1b78bef814d6d459499276cdf5 (MD5) Previous issue date: 2011
Resumo: A ritmicidade circadiana, expressa na alteração do comportamento e em aspectos morfofisiológicos e moleculares ao longo das 24 horas do dia, é uma das funções básicas dos organismos vivos. Os processos comportamentais e os mecanismos moleculares no hipocampo, que estão envolvidos na aprendizagem e memória, demonstram oscilação circadiana. Vários estudos sugeriram que o condicionamento clássico aversivo é afetado pelo sistema de temporização circadiana e que a oscilação circadiana de vias moleculares específicas é requerida para a consolidação da memória aversiva. O presente trabalho investigou a oscilação circadiana da expressão da nNOS e da atividade da proteína NOS no hipocampo de pombos e as suas relações com a modulação temporal do condicionamento contextual aversivo. Na Parte I, caracterizou-se o padrão temporal da expressão da nNOS, que foi detectada por Western Blotting e o padrão temporal da atividade enzimática da NOS, determinada pela quantidade de L-citrulina produzida por minuto e por micrograma de proteína na reação. Na Parte II, nos horários de mínima e máxima atividade enzimática da proteína, pombos foram treinados e testados em condicionamento aversivo ao contexto. As sessões foram gravadas para posterior análise comportamental. Após o teste foi realizada a imunoistoquímica para marcação da nNOS em neurônios do hipocampo. Foi evidenciada ritmicidade circadiana significativa (p < 0,05) na expressão protéica da nNOS e na atividade enzimática da NOS, segundo os valores fornecidos pelo método Cosinor para caracterização do padrão temporal. As médias da densitometria óptica dos grupos com horários mais próximos da acrofase - ZT04 (10hs; 0,944 ± 0,12) e a batifase - ZT16-(22hs; 0,572 ± 0,16) foram significativamente diferentes (F5,18 p < 0,0001). Os grupos condicionados, em ambos os horários, mostraram maior duração e maior ocorrência do comportamento de congelamento do que os controles (p < 0,05). Houve uma variação dia-noite para o comportamento de congelamento nos grupos controles (p < 0,05). A marcação de células nNOS-positivas foi maior no hipocampo dos grupos condicionados sendo que o total de células nNOS-positivas na área dorsal do grupo experimental testado à noite foi maior do que aquele observado nos grupos controles e no experimental da manhã (p < 0,05). Os dados mostraram que a expressão protéica da nNOS e da atividade enzimática da NOS no hipocampo de pombos mostram uma oscilação que caracteriza um padrão temporal circadiano. Tanto no horário de máxima como no de mínima atividade da nNOS, o condicionamento contextual aversivo resultou em medo condicionado ao contexto e em expressão de células nNOS-positivas no hipocampo que foi maior nos pombos condicionados do que nos controles. Contudo, no hipocampo do grupo testado à noite houve um maior número de células nNOS-positivas. Esse dado estimula questionamento sobre se ocorreria a ativação de mecanismos compensatórios para o aumento da expressão da proteína nNOS, quanto essa é requisitada em situações de baixa disponibilidade
Abstract: The circadian rhythm, expressed in changing behavior and the morphophysiologic and molecular aspects over 24 hours of the day is one of the basic functions of living organisms. The behavioral processes and molecular mechanisms in the hippocampus, which are involved in learning and memory, show circadian oscillation. Several studies have suggested that classical fear conditioning is affected by the circadian timing system and the circadian oscillation of specific molecular pathways is required for the consolidation of aversive memory. This study investigated the circadian oscillation of nNOS expression and activity of NOS protein in the hippocampus of pigeons and their relationship with the temporal modulation of aversive contextual conditioning. In Part I, we have characterized the temporal pattern of nNOS expression, which was detected by Western blotting and temporal pattern of NOS enzyme activity, determined by the amount of L-citrulline produced per minute and per microgram of protein in the reaction. In Part II, at the times of minimum and maximum activity of the protein, pigeons were trained and tested in aversive conditioning to context. The sessions were taped for later behavioral analysis. After the test was performed immunohistochemical for labeling of nNOS in neurons in the hippocampus. Circadian rhythm was evident (p <0.05) in nNOS protein expression and enzyme activity of NOS, according to figures provided by Cosinor method to characterize the temporal pattern. The mean optical density of groups with times closer to the acrophase - ZT04 (10hrs; 0.944 ± 0.12) and nadir - ZT16-(22hs; 0.572 ± 0.16) were significantly different (F5, 18 p <0.0001 ). The groups conditioned in both schedules, showed more frequent and longer duration of freezing behavior than controls (p <0.05). There was a day-night variation for freezing behavior in control groups (p <0.05). Labeling of nNOS-positive cells was higher in the hippocampus of the groups conditioned with total nNOS-positive cells in the dorsal area of the experimental group tested at night was higher than that observed in control groups and experimental group in the morning (p <0.05). The data showed that nNOS protein expression and enzymatic activity of NOS in the hippocampus of pigeons show an oscillation that characterizes a circadian temporal pattern. Both at the time of maximum as the low activity of nNOS, the aversive contextual conditioning resulted in fear conditioning to context and expression of nNOS-positive cells in the hippocampus was higher in pigeons conditioned than in controls. However, in the hippocampus of the group tested in the evening there was a greater number of nNOS-positive cells. This fact encourages questioning of whether there would be activation of compensatory mechanisms for the increased expression of nNOS protein, as this is required in situations of low availability
Mestrado
Fisiologia
Mestre em Biologia Funcional e Molecular

APA, Harvard, Vancouver, ISO, and other styles

32

Faria, Larissa Oliveira Melloni de 1985. "Participação da sintase neuronal de óxido nítrico (nNOS) na consolidação e reconsolidação da memória do condicionamento clássico aversivo em pombos (Columba livia)." [s.n.], 2013. http://repositorio.unicamp.br/jspui/handle/REPOSIP/314128.

Full text

Abstract:

Orientador: Elenice Aparecida de Moraes Ferrari
Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia
Made available in DSpace on 2018-08-23T06:24:39Z (GMT). No. of bitstreams: 1 Faria_LarissaOliveiraMellonide_M.pdf: 1121073 bytes, checksum: 5a3108ca0447b5fae98988b4611d7616 (MD5) Previous issue date: 2013
Resumo: O óxido nítrico (NO) é um neurotransmissor não convencional o qual tem papel importante em processos neurobiológicos de comportamento e de memória. Sua síntese é mediada por três isoformas de sintase do óxido nítrico (NOS): a neuronal (nNOS), a endotelial (eNOS) e a induzível (iNOS). Este trabalho investigou os efeitos da administração do 7- nitroindazol (7-NI), inibidor preferencial da nNOS, na consolidação e reconsolidação da memória do condicionamento clássico aversivo. Pombos adultos foram atribuídos a 5 grupos: Foram usados 5 grupos: grupo 7-nitroindazole (7-NI) (100nmol/0.5?/l; DMSO (20%), NaOH (50mM) e Tween-80 (16%) diluído em PBS; i.c.v.), grupo veículo (VEIC) (0,5?/l; DMSO (20%), NaOH (50mM) e Tween-80 (16%) diluído em PBS, i.c.v.), grupo condicionado/não tratado (COND), grupo contexto/não-tratado (CONT) e grupo não tratado/não condicionado (NÄIVE). Sete dias após implante de microcânula intracerebroventricular (i.c.v.), ocorreu o condicionamento com três associações contextochoque numa sessão de 20 min. O teste e o re-teste consistiram na re-exposição ao contexto do condicionamento por 5 min. O intervalo entre sessões foi de 24h. A administração de 7-NI ou do veículo ocorreu imediatamente após o treino (Experimento 1) ou após o re-teste (Experimento 2). A atividade enzimática da NOS dependente e independente de Ca2+ e da expressão protéica da nNOS foram realizadas no tecido hipocampal. No Experimento 1, a ocorrência de congelamento no teste do 7-NI foi menor do que no treino (p<0.01) e no teste do COND e VEIC (p < 0.001). A atividade da NOS dependente de Ca++ no 7-NI foi menor do que no COND e VEIC (p<0,01), mas não diferiu do CONT e do NÄIVE. A expressão protéica de nNOS não diferiu entre os grupos (p<0,05). No Experimento 2, houve diminuição dos comportamentos defensivos, incluindo o congelamento, no re-teste do 7-NI comparado com VEIC e COND (p<0.05), mas os grupos não diferiram quanto à atividade de NOS dependente de Ca2+ ou à expressão protéica da nNOS. Conclui-se que o 7-NI interferiu na consolidação e a reconsolidação da memória, indicando a ativação da via de sinalização do óxido nítrico no hipocampo em processos da memória de medo condicionado ao contexto em pombos
Abstract: Nitric oxide (NO) is an unconventional neurotransmitter which plays an important role in neurobiological processes of behavior and memory. Its synthesis is mediated by three isoforms of nitric oxide synthase (NOS): the neuronal (nNOS), the endothelial (eNOS) and the inducible (iNOS). This study investigated the effects of the administration of 7- nitroindazole (7-NI), a preferential nNOS inhibitor, in the consolidation and reconsolidation of aversive classical conditioning memory. Adult male pigeons were assigned to 5 groups: 7-nitroindazole, 7-NI (100nmol/0.5?/l; DMSO (20%), NaOH (50 mM) and Tween-80 (16%) diluted in PBS; i.c.v.) Vehicle group; VEH (0.5 ? / L; DMSO (20%), NaOH (50 mM) and Tween-80 (16%) diluted in PBS; i.c.v.), conditioning/non-treated group (COND), context/non-treated group (CONT) and non-conditioning/non-treated group (NÄIVE). Seven days after implantation of intracerebral ventricular (i.c.v.) microcannula the conditioning occurred with three context-shock associations in a session of 20 min. During the testing and retesting sessions pigeons were reexposed to the conditioning context for 5 min. The between sessions interval was 24h. Administration of 7-NI or vehicle occurred immediately after training (Experiment 1) or after testing (Experiment 2). The enzymatic activity of Ca2+ dependent and independent NOS and protein expression of nNOS in the hippocampus tissue were carried out following the behavioral test or retest. In Experiment 1, the occurrence of freezing in the testing session of 7-NI group was lower than in the training (p <0.01) and the testing sessions of COND and VEH groups (p <0.001). The activity of Ca2+ dependent NOS in the 7-NI group was lower than in COND and VEH groups (p <0.01) but did not differ from CONT and NÄIVE groups. The nNOS protein expression in the hippocampus did not differ among the different groups (p<0.05). In Experiment 2, there was a decrease of defensive behaviors, which include freezing, in the retest of the 7-NI compared with VEH and COND groups (p <0.05), but the groups did not differ in the activity of Ca2+ dependent NOS or the protein expression of nNOS. We conclude that 7-NI interfered on the consolidation and reconsolidation of memory, indicating activation of the nitric oxide signaling pathway in the hippocampus and in memory processes of conditioned fear context in pigeons
Mestrado
Fisiologia
Mestra em Biologia Funcional e Molecular

APA, Harvard, Vancouver, ISO, and other styles

33

Luis, Delgado Oliva Erendira. "Etude de l'induction de DeltaFosB dans la moëlle épinière lors d'une stimulation nociceptive de type inflammatoire et de ses relations avec nNOS." Université Louis Pasteur (Strasbourg) (1971-2008), 2006. https://publication-theses.unistra.fr/public/theses_doctorat/2006/LUIS_DELGADO_Oliva_Erendira_2006.pdf.

Full text

Abstract:

La douleur inflammatoire est souvent étudiée en injectant par voie sous-cutanée des agents tels que la carragénine dans la voûte plantaire des rats. Alors que la plupart des travaux utilisant la carragénine sont consacrés à la phase aiguë, nous nous sommes intéressés à la phase tardive de cette douleur soutenue. L’œdème de la patte et l’activité de la myélopéroxydase, révélatrice de l’invasion des neutrophiles, sont utilisés comme marqueurs de l’inflammation. Ils montrent que celle-ci atteint un maximum 6 h après l’injection et persiste pendant au moins 3 jours. L’hyperalgie mécanique est étudiée avec un nouveau modèle de pince calibrée dont le fonctionnement est préalablement validé. Celle-ci s’installe dès les premières heures et persiste pendant 7 jours. Les phénomènes de plasticité neuronale contribuent vraisemblablement à entretenir la douleur soutenue. Cette hypothèse nous a conduit à rechercher l’expression du facteur de transcription ∆FosB dans la moelle épinière en raison de sa capacité d’accumulation à long terme. L’expression de ∆FosB est révélée en utilisant deux anticorps dont l’un est dirigé contre les deux facteurs ∆FosB et FosB (anticorps anti-FosB/ΔFosB) et l’autre exclusivement contre FosB (anticorps anti-FosB). Le marquage obtenu avec l’anticorps anti-FosB/∆FosB persiste pendant 7 jours tandis que le marquage obtenu avec l’anticorps anti-FosB disparaît après 24 h. L’anticorps anti FosB/ΔFosB révèle donc l’expression de ∆FosB après cette durée. Le décours temporel de l’expression de ∆FosB suggère que ce facteur intervient sur la plasticité neuronale dans la moelle épinière lors d’une douleur soutenue. Il peut donc être utilisé comme marqueur de cette douleur soutenue. Le double marquage ∆FosB/nNOS montre que la co-localisation des deux anticorps est fréquente dans les cellules marquées par ∆FosB. Ces expériences suggèrent que l’activité de nNOS contribue à l’expression de ∆FosB. L’ensemble de ces résultats suggère donc que la douleur inflammatoire persiste pendant plusieurs jours par suite de l’activation de l’expression de gènes dépendant du facteur de transcription ∆FosB, l’expression de ce facteur de transcription dépendant elle-même du NO libéré par des neurones exprimant nNOS.

APA, Harvard, Vancouver, ISO, and other styles

34

Dezengrini, Renata. "HERPESVÍRUS BOVINO TIPOS 1, 2 E 5: SENSIBILIDADE A ANTIVIRAIS IN VITRO, PATOGENIA E TERAPÊUTICA EXPERIMENTAL EM COELHOS." Universidade Federal de Santa Maria, 2009. http://repositorio.ufsm.br/handle/1/4039.

Full text

Abstract:

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Aspects of bovine herpesvirus 5 (BoHV-5) pathogenesis and experimental therapies against BoHV-1 and BoHV-5 were investigated in vitro and in inoculated rabbits. In chapter 1, we investigated the role of nitric oxide (NO), a component of innate immunity against pathogens, in the neurological disease by BoHV-5 in rabbits. Spectrophotometry for NO products revealed that NO levels were significantly increased in several regions of the brain of rabbits with neurological disease [F(4, 40)=3.33; P<0.02]. Quantification of NO levels in the brain at different time points after virus inoculation revealed a gradual increase [F(12, 128)=2.82; P<0,003], correlated spatially and temporally with virus dissemination within the brain and preceding the development of neurological signs. Thus, we propose that the overproduction of NO in the brain of BoHV-5-infected rabbits may participate in the pathogenesis of neurological disease. In chapter 2, the activity of three anti-herpetic drugs was tested against BoHV-1, BoHV-2 and BoHV-5 in vitro by plaque reduction assay. Acyclovir was moderately active against the three viruses; Gancyclovir was moderately effective against BoHV-2, and to a lesser extent against BoHV-5, being poorly active against BoHV-1. Foscarnet (PFA) exhibited the most pronounced antiviral activity, being the only drug that, at the concentration of 100 ìg/mL, completely inhibited plaque formation by all three viruses. In chapter 3, we report the activity of PFA in rabbits inoculated with BoHV-1 or BoHV-5. Rabbits inoculated with BoHV-5 and treated with 100 mg/kg of PFA presented mortality rates (11/22 or 50%) statistically lower than non-treated controls (21/22 ou 95.4%) (P<0.0008). A significant reduction in the mean virus titers was observed at day 3 pi, the peak of virus shedding [F(9,108) = 2,23; P<0.03]. Reduction in virus shedding, frequency, severity and duration of ocular signs were also observed in rabbits inoculated with BoHV-1 into the conjunctival sac, comparing to the controls. The prolonged incubation period and the reduction in the duration of the clinical course of the PFA-treated group was significant (P<0.005 and P<0.04, respectively). Therefore, the activity of PFA in vivo against BoHV-1 and BoHV-5 may be exploited in further experimental therapies. In chapter 4, we investigated the effect of the inhibition of the inducible isoform of nitric oxide synthase (iNOS), associated or not with PFA treatment, on neurological infection by BoHV-5 in rabbits. Groups of BoHV-5-inoculated rabbits were treated with the iNOS inhibitor aminoguanidine (AG); with PFA; with both drugs; or maintained as virus controls. Morbidity and mortality rates were 100% (6/6) in the groups AG and CV, 66.7% (4/6) in the group PFA and 83.3% (5/6) in the group AG+PFA. The incubation period was significantly lower (P<0.05) and the onset of neurological disease occurred earlier and was more severe in the group AG. These results demonstrate that treatment with PFA reduced morbidity and mortality rates associated to BoHV-5 infection, that AG treatment anticipated the development of neurological signs, and that the development of neurolocial disease was delayed in the group treated with both drugs. Taken together, these results contribute to the knowledge of the pathogenesis of BoHV-5 neurological disease and pave the way for other experimental pathogenesis and therapy studies.
Aspectos da patogenia da infecção neurológica pelo herpesvírus bovino 5 (BoHV-5) e terapias experimentais contra o BoHV-1 e BoHV-5 foram estudados in vitro e em coelhos inoculados. O capítulo 1 relata a investigação do papel do óxido nítrico (NO), um componente da imunidade inata contra patógenos, na doença neurológica produzida pelo BoHV-5 em coelhos. Espectrofotometria para os produtos de degradação do NO revelou um aumento significativo nos seus níveis em várias regiões do encéfalo de coelhos infectados (F(4, 40)=3.33; P<0,02). A quantificação do NO no encéfalo nos dias seguintes à inoculação viral revelou um aumento gradativo (F(12, 128)=2.82; P<0,003), correlacionado temporal e espacialmente com a invasão e disseminação viral, e precedendo o desenvolvimento de sinais neurológicos. Sugere-se, assim, que a produção aumentada de NO em resposta à infecção possa participar da patogenia dessa doença neurológica. No capítulo 2, investigou-se a atividade de três fármacos antivirais frente ao BoHV-1, BoHV-2 e BoHV-5 in vitro pelo teste de redução do número de placas. O Aciclovir foi moderadamente ativo frente aos três vírus; o Ganciclovir apresentou atividade moderada frente ao BoHV-2 e, em menor grau, contra o BoHV-5, sendo ineficaz frente ao BoHV-1. O Foscarnet (PFA) apresentou a atividade antiviral mais pronunciada, sendo o único fármaco que, na concentração de 100 μg/mL, inibiu completamente a produção de placas pelos três herpesvírus bovinos. No capítulo 3, investigou-se a atividade do PFA em coelhos inoculados com o BoHV-1 ou BoHV-5. Coelhos inoculados com o BoHV-5 e tratados com 100 mg/kg do PFA apresentaram índices de mortalidade (11/22; 50%) estatisticamente inferiores aos controles não-tratados (21/22; 93,7%) (P<0,0008). Uma redução significativa no título médio de vírus foi observada no dia 3 pi, pico da excreção viral [F(9,108) = 2,23; P<0,03]. Em coelhos inoculados no saco conjuntival com o BoHV-1 e tratados com o PFA, foram observadas reduções na excreção viral, na frequência, severidade comparando-se com o grupo controle. O período de incubação prolongado e a redução na duração do curso clínico no grupo tratado foi significante (P<0,005 e P<0,04, respectivamente). A atividade antiviral do PFA in vivo contra o BoHV-1 e BoHV-5 abre a perspectiva para outras terapias experimentais. No capítulo 4, investigou-se o efeito da inibição da isoforma induzível da enzima óxido nítrico sintase (iNOS), associada ou não ao tratamento com o PFA, na infecção neurológica pelo BoHV-5 em coelhos. Grupos de coelhos inoculados com o BoHV-5 foram tratados com o inibidor da iNOS aminoguanidina (AG); com PFA; com ambos os fármacos; ou não receberam tratamento. Os índices de morbidade e mortalidade foram de 100% (6/6) nos grupos AG e controle; 66,7% (4/6) no grupo PFA e 83,3% (5/6) no grupo AG+PFA. O período de incubação foi significativamente menor (P<0,05) e os sinais neurológicos foram mais precoces e severos nos animais do grupo AG. Portanto, o tratamento com PFA reduziu a morbidade e mortalidade associadas com a infecção pelo BoHV-5; o tratamento com AG resultou no agravamento e na antecipação do quadro neurológico e no grupo tratado com ambos os fármacos observou-se um desenvolvimento mais tardio dos sinais neurológicos. Esses resultados contribuem para o conhecimento da patogenia da doença neurológica pelo BoHV-5 e abrem perspectivas para estudos adicionais de patogenia e terapêutica anti-herpesvírus.

APA, Harvard, Vancouver, ISO, and other styles

35

Pierson, Shawn M. "Aspects of the transcriptional and translational regulation of nitric oxide synthase 1." Connect to this title online, 2005. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1111595828.

Full text

Abstract:

Thesis (Ph. D.)--Ohio State University, 2005.
Title from first page of PDF file. Document formatted into pages; contains x, 156 p.; also includes graphics (some col.) Includes bibliographical references (p. 146-156). Available online via OhioLINK's ETD Center

APA, Harvard, Vancouver, ISO, and other styles

36

Moszkowicz, David. "Etude anatomique et fonctionnelle de l'innervation pelvipérinéale de la femme : cartographie tridimensionnelle de l'expression de la forme neurale de l'enzyme de synthèse de l'oxyde nitrique (nNOS)." Phd thesis, Université Paris Sud - Paris XI, 2012. http://tel.archives-ouvertes.fr/tel-00775860.

Full text

Abstract:

Si les connaissances anatomiques supportent l'élaboration des techniqueschirurgicales, peu d'informations étaient disponibles sur l'anatomie et la physiologie del'innervation pelvi-périnéale. La détermination précise de l'origine, du trajet péri-viscéral, desrapports anatomiques avec les organes et les vaisseaux de voisinage et de la terminaison deces nerfs au niveau d'organes dont ils commandent la fonction était jusqu'alors peu accessibleaux techniques anatomiques classiques de dissection macroscopique sur sujet cadavérique.Dans le domaine de la chirurgie pelvienne pour cancer, l'amélioration de la qualité de vie desmalades passe par la préservation de ces structures nerveuses, la dimension fonctionnelle étantdésormais indissociable des impératifs carcinologiques. En effet, l'intégrité de ces nerfs estindispensable aux fonctions de continence sphinctérienne et de sexualité. Par ailleurs, lamajorité des travaux s'intéressant aux séquelles fonctionnelles postopératoires sont réaliséschez l'homme et très peu de travaux concernent exclusivement les femmes dont les troublessexuels sont plus difficiles à identifier. La réduction de ces troubles fonctionnelspostopératoires passe donc par une meilleure compréhension de l'anatomie nerveuse pelvipérinéale,qui peut être éclaircie par de nouvelles techniques d'étude

APA, Harvard, Vancouver, ISO, and other styles

37

Moszkowicz, David. "Etude anatomique et fonctionnelle de l’innervation pelvipérinéale de la femme : cartographie tridimensionnelle de l’expression de la forme neurale de l’enzyme de synthèse de l’oxyde nitrique (nNOS)." Thesis, Paris 11, 2012. http://www.theses.fr/2012PA114836/document.

Full text

Abstract:

Si les connaissances anatomiques supportent l’élaboration des techniqueschirurgicales, peu d’informations étaient disponibles sur l’anatomie et la physiologie del’innervation pelvi-périnéale. La détermination précise de l’origine, du trajet péri-viscéral, desrapports anatomiques avec les organes et les vaisseaux de voisinage et de la terminaison deces nerfs au niveau d’organes dont ils commandent la fonction était jusqu’alors peu accessibleaux techniques anatomiques classiques de dissection macroscopique sur sujet cadavérique.Dans le domaine de la chirurgie pelvienne pour cancer, l’amélioration de la qualité de vie desmalades passe par la préservation de ces structures nerveuses, la dimension fonctionnelle étantdésormais indissociable des impératifs carcinologiques. En effet, l’intégrité de ces nerfs estindispensable aux fonctions de continence sphinctérienne et de sexualité. Par ailleurs, lamajorité des travaux s’intéressant aux séquelles fonctionnelles postopératoires sont réaliséschez l’homme et très peu de travaux concernent exclusivement les femmes dont les troublessexuels sont plus difficiles à identifier. La réduction de ces troubles fonctionnelspostopératoires passe donc par une meilleure compréhension de l’anatomie nerveuse pelvipérinéale,qui peut être éclaircie par de nouvelles techniques d’étude
Anatomical knowledge is required for the development of surgical techniques,but little is known about the anatomy and physiology of innervation in the pelvic/perinealarea. The origin, perivisceral trajectory, anatomical relationships to organs and neighbouringvessels and of the endings of these nerves in the organs they control has not, to date, beeneasy to determine precisely by classical anatomical techniques based on the macroscopicdissection of cadavers. In the domain of pelvic cancer surgery, improvements in the quality oflife of patients are dependent on the preservation of these nervous system structures; themaintenance of function cannot be dissociated from oncological imperatives. Indeed, theintegrity of these nerves is essential for sphincter continence and sexual functions. Moststudies have focused on the functional sequelae of surgery in men. Very few studies havefocused exclusively on women, in whom sexual problems are more difficult to identify. Thereduction of such postsurgical functional problems thus requires a more completeunderstanding of the anatomy of the pelvic/perineal nervous system. This may be possiblethrough the use of new investigative techniques

APA, Harvard, Vancouver, ISO, and other styles

38

Jurzik, Lars. "Veränderung der neuronalen Vasoregulation im mesenterialen Gefässbett bei portaler Hypertension mit besonderem Fokus auf die neuronale Stickstoffmonoxyd-Synthase (nNOS)-vermittelte Vasorelaxation und die Neuropeptid-Y-(NPY)-induzierte Vasokonstriktion /." [S.l.] : [s.n.], 2004. http://deposit.ddb.de/cgi-bin/dokserv?idn=973326840.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Tajouri, Lotfi, and n/a. "Gene Expression Analysis and Genetic Studies in Multiple Sclerosis." Griffith University. School of Health Science, 2005. http://www4.gu.edu.au:8080/adt-root/public/adt-QGU20060111.123933.

Full text

Abstract:

Multiple Sclerosis (MS) is a neurodegenerative disease of the central nervous system (CNS). As part of this disorder the myelin sheath undergoes degeneration, leading to alterations in the conductivity of axons, and impaired function. The onset of the disease occurs in young adults and clinical pathology is characterised by varying severity. These include i) Relapsing Remitting MS (RR-MS), ii) Secondary Progressive MS (SP-MS) and iii) Primary Progressive MS (PP-MS). MS is more prevalent in women and accounts for more than two thirds of all MS sufferers. MS is considered to be a multifactorial disorder with both genetic and environmental components. The prevalence of MS is dependent on geographical localisation, with lower sunlight exposure linked to higher prevalence. Also, studies show an increased risk in close relatives, or in identical twins, indicating a significant genetic component to the disorder. There are a number of genes that may plausibly be involved in MS pathophysiology. These include myelin-related genes, such as the myelin basic protein (MBP), immune-related genes, such FC receptor and osteopontin, and heat shock proteins such as xb crystallin. These candidate genes have been implicated in a variety of ways but usually through immunological and/or genetic studies. One of the most consistent findings in recent years has been the association of disease with alterations in the specific major histocompatibility complex (MHC) localised to chromosome 6p21.3, and includes MHC I, II, III. Genome wide screens have permitted the identification of loci in the genome, which are associated with MS susceptibility. The number of genes involved in MS is unknown and several case-control association studies have been undertaken to reveal the involvement of potential candidate genes. In general terms, current research is aimed at determining allelic variation of candidate genes. Such genes have been implicated in MS because they reside within susceptible regions of the chromosome associated with MS or they have a plausible potential pathophysiological role in MS. Candidate loci investigated in this study, for association with MS susceptibility, include members of the nitric oxide synthase family of metabolic proteins (inducible NOS, iNOS/NOS2A and neuronal NOS, nNOS), methylenetetrahydrofolate reductase (MTHFR), catechol-O-methyl transferase (COMT), and vitamin D receptor (VDR). The MS population used in all studies consisted of over 100 MS cases and gender, age and ethnicity matched controls. In our study of inducible and neuronal NOS genes, PCR based assays were developed to amplify a region of both promoters that contained known microsatellite variation. Supporting phyisological data suggests that the neuroinflammatory aspects of MS are associated with aberrant NO production, which may be due to aberrant regulation of NOS activity. Specific amplified products were identified by fluorescent capillary electrophoresis and allele frequencies were statistically compared using chi-squared analysis. In the nNOS and iNOS study, no association was identified with allele frequency variation and MS susceptibility (nNOS: ?2=5.63, P=0.962; iNOS: ?2=3.4; P=0.082). Similarly, no differences in allele frequencies were observed for gender or clinical course for both markers (Pvalue greater than 0.05). In short, results from this study indicate that the NOS promoter variations studied do not play a significant role in determining susceptibility to MS in the tested population. The COMT and MTHFR genes are localised at 22q12-13 and 1p36.3 respectively, regions of the genome that have been found to be positively associated with MS susceptibility. In our research, we set out to examine the G158A change in the 4th exon of the COMT gene. This functional mutation leads to an amino acid change (valine to methionine) that is directly associated with changes in the activity of COMT. The MTHFR enzyme plays a role in folate metabolism, and can be implicated in the turnover of homocysteine. Previous investigations have shown that high levels of homocysteine are encountered in MS patients, where it is also linked to demyelination in the CNS. In our study the aim was to examine the C677T variation (alanine to valine amino acid change) in the exon 4 coding region of the MTHFR gene and the G158A variation in the COMT gene. Restriction fragment length polymorphism (RFLP) analysis and gel electrophoresis was used to identify specific alleles for both COMT and MTHFR. However, as with the NOS study, no specific association was identified between MS susceptibility and variation for either of the tested COMT or MTHFR (Pvalue greater than 0.05) variants. In a final genomic investigation of the MS population, three variations in the VDR gene were analysed for association with MS susceptibility and pathology. Using RFLP analysis, three VDR variants were investigated with genotypes detected using the Taq I, Apa I and Fok I restriction enzymes. In contrast to previous genotypic analyses, this study did show a positive association, specifically between the functional variation in exon 9 of the VDR gene and MS (Taq I, 2= 7.22, P= 0.0072). Interestingly, the Apa I variant of VDR was also found to be associated with MS ( 2=4.2, P=0.04). The Taq I and Apa I variants were also found to be in very strong and significant linkage disequilibrium (D'=0.96, Pvalue less than 0.0001) and their associations were more prominent with the progressive forms of MS (SP-MS and PP-MS). In addition to genotypic analysis of a clinical population, additional research was undertaken to identify novel targets for MS susceptibility studies. Global gene expression analysis was undertaken using comparative subtractive fluorescent microarray technology to examine differences in gene activity (expression) in age and sex matched MS plaque tissue and anatomically matched normal white matter (NWM). MS plaques were obtained post mortem from MS sufferers with no drug history in the last two months before death and matched anatomically to healthy white matter from donors with no previous neurological disorders. Target arrays consisted of 5000 cDNAs and analysis was conducted using the Affymetrix 428 scanner. In this way, 139 genes were shown to be differentially regulated in MS plaque tissue compared to NWM. Of these, 69 genes showed a common pattern of expression in the chronic active and acute plaque tissues investigated (Pvalue less than 0.0001, a=0.73); while 70 transcripts were uniquely differentially expressed ( 1.5-fold) in either acute or chronic active lesions. To validate the gene expression profile results, quantitative real time reverse transcriptase (RT) PCR (Q-PCR) analysis was performed. 12 genes were selected because they were shown to be differentially expressed by array analysis in this study, or because of their involvement in MS pathology. These included transferrin (TF), superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPX1), glutathione S-transferase pi (GSTP1), crystallin, alpha-B (CRYAB), phosphomannomutase 1 (PMM1), tubulin beta-5 (TBB5), inositol 1,4,5-trisphosphate 3-kinase B (ITPKB), calpain 1 (CAPNS1), osteopontin (SPP1 or OPN), as well as the signal transducer and activator of transcription 1 (STAT1) and protein inhibitor of activated STAT1 (PIAS1). Both absolute (copy number) and comparative differences in the relative levels of expression in MS lesions and NWM were determined for each gene. The results from this study revealed a significant correlation of real time PCR results with the microarray data, while a significant correlation was also found between comparative and absolute determinations of fold. As with the results of array analysis, a significant difference in gene expression patterning was identified between chronic active and acute plaque pathologies. For example, a up to 50-fold increase in SPP1 and ITPKB levels in acute plaques contrasted with the 5-fold or less increase in chronic active plaques (P less than 0.0.1, unpaired t-Test). Of particular note, gamma-amino butyric acid receptor ?2 (GABG2), integrin ?5 (ITGB5), complement component 4B (C4B), parathyroid hormone receptor 1 (PTHR1) were found up-regulated in MS and glial derived neurotropic factor ?2 (GDNFA2), insulin receptor (INSR), thyroid hormone receptor ZAKI4 (ZAKI4) were found down-regulated in MS. Data also revealed a decreased expression of the immune related genes STAT1 and PIAS1 in acute plaques. In conclusion, this research used both genomic analysis and technologies in gene expression to investigate both known and novel markers of MS pathology and susceptibility. The study developed tools that may be used for further investigation of clinical pathology in MS and have provided interesting initial expression data to further investigate the genes that play a role in MS development and progression.

APA, Harvard, Vancouver, ISO, and other styles

40

Tajouri, Lotfi. "Gene Expression Analysis and Genetic Studies in Multiple Sclerosis." Thesis, Griffith University, 2005. http://hdl.handle.net/10072/366467.

Full text

Abstract:

Multiple Sclerosis (MS) is a neurodegenerative disease of the central nervous system (CNS). As part of this disorder the myelin sheath undergoes degeneration, leading to alterations in the conductivity of axons, and impaired function. The onset of the disease occurs in young adults and clinical pathology is characterised by varying severity. These include i) Relapsing Remitting MS (RR-MS), ii) Secondary Progressive MS (SP-MS) and iii) Primary Progressive MS (PP-MS). MS is more prevalent in women and accounts for more than two thirds of all MS sufferers. MS is considered to be a multifactorial disorder with both genetic and environmental components. The prevalence of MS is dependent on geographical localisation, with lower sunlight exposure linked to higher prevalence. Also, studies show an increased risk in close relatives, or in identical twins, indicating a significant genetic component to the disorder. There are a number of genes that may plausibly be involved in MS pathophysiology. These include myelin-related genes, such as the myelin basic protein (MBP), immune-related genes, such FC receptor and osteopontin, and heat shock proteins such as xb crystallin. These candidate genes have been implicated in a variety of ways but usually through immunological and/or genetic studies. One of the most consistent findings in recent years has been the association of disease with alterations in the specific major histocompatibility complex (MHC) localised to chromosome 6p21.3, and includes MHC I, II, III. Genome wide screens have permitted the identification of loci in the genome, which are associated with MS susceptibility. The number of genes involved in MS is unknown and several case-control association studies have been undertaken to reveal the involvement of potential candidate genes. In general terms, current research is aimed at determining allelic variation of candidate genes. Such genes have been implicated in MS because they reside within susceptible regions of the chromosome associated with MS or they have a plausible potential pathophysiological role in MS. Candidate loci investigated in this study, for association with MS susceptibility, include members of the nitric oxide synthase family of metabolic proteins (inducible NOS, iNOS/NOS2A and neuronal NOS, nNOS), methylenetetrahydrofolate reductase (MTHFR), catechol-O-methyl transferase (COMT), and vitamin D receptor (VDR). The MS population used in all studies consisted of over 100 MS cases and gender, age and ethnicity matched controls. In our study of inducible and neuronal NOS genes, PCR based assays were developed to amplify a region of both promoters that contained known microsatellite variation. Supporting phyisological data suggests that the neuroinflammatory aspects of MS are associated with aberrant NO production, which may be due to aberrant regulation of NOS activity. Specific amplified products were identified by fluorescent capillary electrophoresis and allele frequencies were statistically compared using chi-squared analysis. In the nNOS and iNOS study, no association was identified with allele frequency variation and MS susceptibility (nNOS: ?2=5.63, P=0.962; iNOS: ?2=3.4; P=0.082). Similarly, no differences in allele frequencies were observed for gender or clinical course for both markers (Pvalue greater than 0.05). In short, results from this study indicate that the NOS promoter variations studied do not play a significant role in determining susceptibility to MS in the tested population. The COMT and MTHFR genes are localised at 22q12-13 and 1p36.3 respectively, regions of the genome that have been found to be positively associated with MS susceptibility. In our research, we set out to examine the G158A change in the 4th exon of the COMT gene. This functional mutation leads to an amino acid change (valine to methionine) that is directly associated with changes in the activity of COMT. The MTHFR enzyme plays a role in folate metabolism, and can be implicated in the turnover of homocysteine. Previous investigations have shown that high levels of homocysteine are encountered in MS patients, where it is also linked to demyelination in the CNS. In our study the aim was to examine the C677T variation (alanine to valine amino acid change) in the exon 4 coding region of the MTHFR gene and the G158A variation in the COMT gene. Restriction fragment length polymorphism (RFLP) analysis and gel electrophoresis was used to identify specific alleles for both COMT and MTHFR. However, as with the NOS study, no specific association was identified between MS susceptibility and variation for either of the tested COMT or MTHFR (Pvalue greater than 0.05) variants. In a final genomic investigation of the MS population, three variations in the VDR gene were analysed for association with MS susceptibility and pathology. Using RFLP analysis, three VDR variants were investigated with genotypes detected using the Taq I, Apa I and Fok I restriction enzymes. In contrast to previous genotypic analyses, this study did show a positive association, specifically between the functional variation in exon 9 of the VDR gene and MS (Taq I, 2= 7.22, P= 0.0072). Interestingly, the Apa I variant of VDR was also found to be associated with MS ( 2=4.2, P=0.04). The Taq I and Apa I variants were also found to be in very strong and significant linkage disequilibrium (D'=0.96, Pvalue less than 0.0001) and their associations were more prominent with the progressive forms of MS (SP-MS and PP-MS). In addition to genotypic analysis of a clinical population, additional research was undertaken to identify novel targets for MS susceptibility studies. Global gene expression analysis was undertaken using comparative subtractive fluorescent microarray technology to examine differences in gene activity (expression) in age and sex matched MS plaque tissue and anatomically matched normal white matter (NWM). MS plaques were obtained post mortem from MS sufferers with no drug history in the last two months before death and matched anatomically to healthy white matter from donors with no previous neurological disorders. Target arrays consisted of 5000 cDNAs and analysis was conducted using the Affymetrix 428 scanner. In this way, 139 genes were shown to be differentially regulated in MS plaque tissue compared to NWM. Of these, 69 genes showed a common pattern of expression in the chronic active and acute plaque tissues investigated (Pvalue less than 0.0001, a=0.73); while 70 transcripts were uniquely differentially expressed ( 1.5-fold) in either acute or chronic active lesions. To validate the gene expression profile results, quantitative real time reverse transcriptase (RT) PCR (Q-PCR) analysis was performed. 12 genes were selected because they were shown to be differentially expressed by array analysis in this study, or because of their involvement in MS pathology. These included transferrin (TF), superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPX1), glutathione S-transferase pi (GSTP1), crystallin, alpha-B (CRYAB), phosphomannomutase 1 (PMM1), tubulin beta-5 (TBB5), inositol 1,4,5-trisphosphate 3-kinase B (ITPKB), calpain 1 (CAPNS1), osteopontin (SPP1 or OPN), as well as the signal transducer and activator of transcription 1 (STAT1) and protein inhibitor of activated STAT1 (PIAS1). Both absolute (copy number) and comparative differences in the relative levels of expression in MS lesions and NWM were determined for each gene. The results from this study revealed a significant correlation of real time PCR results with the microarray data, while a significant correlation was also found between comparative and absolute determinations of fold. As with the results of array analysis, a significant difference in gene expression patterning was identified between chronic active and acute plaque pathologies. For example, a up to 50-fold increase in SPP1 and ITPKB levels in acute plaques contrasted with the 5-fold or less increase in chronic active plaques (P less than 0.0.1, unpaired t-Test). Of particular note, gamma-amino butyric acid receptor ?2 (GABG2), integrin ?5 (ITGB5), complement component 4B (C4B), parathyroid hormone receptor 1 (PTHR1) were found up-regulated in MS and glial derived neurotropic factor ?2 (GDNFA2), insulin receptor (INSR), thyroid hormone receptor ZAKI4 (ZAKI4) were found down-regulated in MS. Data also revealed a decreased expression of the immune related genes STAT1 and PIAS1 in acute plaques. In conclusion, this research used both genomic analysis and technologies in gene expression to investigate both known and novel markers of MS pathology and susceptibility. The study developed tools that may be used for further investigation of clinical pathology in MS and have provided interesting initial expression data to further investigate the genes that play a role in MS development and progression.
Thesis (PhD Doctorate)
Doctor of Philosophy (PhD)
School of Health Sciences
Full Text

APA, Harvard, Vancouver, ISO, and other styles

41

van, Erp Christel. "Modifying function and fibrosis of cardiac and skeletal muscle from mdx mice." University of Southern Queensland, Faculty of Sciences, 2005. http://eprints.usq.edu.au/archive/00001521/.

Full text

Abstract:

Duchenne Muscular Dystrophy (DMD) is a fatal condition occurring in approximately 1 in 3500 male births and is due to the lack of a protein called dystrophin. Initially DMD was considered a skeletal myopathy, but the pathology and consequences of cardiomyopathy are being increasingly recognised. Fibrosis, resulting from continual cycles of degeneration of the muscle tissues followed by inadequate regeneration of the muscles, is progressive in both cardiac and skeletal dystrophic muscle. In the heart fibrosis interferes with contractility and rhythm whereas it affects contractile function and causes contractures in skeletal muscles. This study utilised the mdx mouse which exhibits a pathological loss of muscle fibres and fibrosis characteristic of DMD, to examine a range of mechanisms that can influence muscle function and fibrosis. Ageing and workload both appear to contribute to the development of dystrophic features in cardiac and skeletal muscle of the mdx mouse. Therefore the effect of eccentric exercise on cardiac and skeletal muscle was examined in older mdx mice. Mice ran in 30 minute sessions for five months, 5 days per week. Downhill treadmill running did not exacerbate the contractile function or fibrosis of the mdx heart or the EDL, SOL or diaphragm muscles suggesting that cytokines influence function and fibrosis to a greater extent than workload alone. The role of the cytokine TGF-beta was examined by treating mdx mice with the TGF-beta antagonist pirfenidone at 0.4, 0.8 or 1.2 per cent in drinking water for six months. Pirfenidone improved cardiac contractility (P<0.01) and coronary flow (P<0.05), to levels comparable to control mice, despite no reduction in cardiac fibrosis. Pirfenidone did not reduce fibrosis or improve function in skeletal muscle. A deficiency of neuronal nitric oxide synthase (nNOS) in DMD and mdx mice causes a lowered production of nitric oxide indicating that the substrate of nNOS, l-arginine, may be beneficial to cardiac and skeletal muscle function in mdx mice. Oral l-arginine (5 mg/g bw) improved cardiac contractility, coronary flow and reduced cardiac fibrosis (P<0.05) without improving skeletal muscle function or fibrosis. In contrast, 10 mg/g bw l-arginine improved cardiac function and coronary flow (P<0.01), despite also elevating cardiac collagen. This increment in collagen was prevented by co-administration of prednisone. The experiments described in this dissertation reveal for the first time that pharmacological treatments in mdx mice can improve cardiac structure and function. Further elucidation of the optimum time and doses of such treatments may result in future pharmacological treatments to improve cardiac function and fibrosis in DMD.

APA, Harvard, Vancouver, ISO, and other styles

42

Chachlaki, Konstantina. "Molecular characterization of NO-synthesizing neurons and assessment of their function in the maturation of the hypothalamic - pituitary - gonadal axis." Thesis, Lille 2, 2016. http://www.theses.fr/2016LIL2S047.

Full text

Abstract:

L’apparition de la puberté et la régulation de la fertilité chez les mammifères sont contrôlées par un réseau neuronal complexe, situé principalement dans l'hypothalamus, et qui converge vers les neurones synthétisant l'hormone de libération des gonadotrophines (GnRH). Ces neurones régulent la sécrétion des gonadotrophines, la croissance et le fonctionnement des gonades. Le développement correct du système à GnRH, incluant des changements rapides dans l'expression et la signalisation de l’hormone GnRH au sein de cette population clairsemée de quelques centaines de neurones, est essentiel pour la maturation sexuelle et le fonctionnement normal de l'axe hypothalamo-hypophyso-gonadique. Lors du développement embryonnaire, ces neurones migrent de la placode olfactive vers leur emplacement définitif, l’hypothalamus, pour y recevoir les connexions afférentes qui permettront une libération pulsatile de la GnRH et la libération subséquente des gonadotrophines (l'hormone de stimulation des follicules (FSH) et l'hormone lutéinisante (LH)). Dès les années 90, l'oxyde nitrique (NO) a été identifié comme molécule clé dans la décharge pré-ovulatoire de GnRH/LH. En effet, de nombreux travaux ont suggéré que des interactions entre les neurones exprimant la forme neuronale de l’enzyme de synthèse du NO (la nNOS) et le système GnRH étaient impliquées dans le contrôle central de la fonction de reproduction à l'âge adulte. De plus, si le NO est reconnu depuis longtemps comme un acteur majeur du contrôle central de l’ovulation à l’âge adulte, la possibilité qu’il soit aussi impliqué dans la maturation sexuelle en régulant l’activité des neurones à GnRH à des stades précoces précédant la puberté n’a pas été explorée auparavant. Cependant, même si nous avons progressé dans la connaissance des interactions entre les neurones à nNOS et des différents acteurs importants de l’axe gonadotrope, l’identité moléculaire de ces neurones reste mal connue. Au cours de cette étude, nous avons recherché 1) l'identité moléculaire des neurones á nNOS dans l'hypothalamus au cours de développement 2) si le NO régule la migration et l’intégration des neurones à GnRH dans l’hypothalamus et 3) si le NO régule la maturation sexuelle. Pendant ma thèse nous avons répertorié pour la première fois les différents neurotransmetteurs et les principaux récepteurs dans les neurones à nNOS au cours du développement post-natal. De plus, les résultats de ma thèse montrent pour la première fois une implication de la signalisation du NO dans la migration des neurones à GnRH vers l'hypothalamus et font échos à l'identification d'une série de mutations de la NOS1 chez des patients atteints du syndrome de Kallmann, une maladie génétique congénitale rare qui associe une carence en GnRH, due à un défaut de migration neuronale, et une anosmie. Enfin, mes travaux montrent que le NO est un nouveau protagoniste dans la maturation post-natale du système à GnRH, la survenue de la puberté et l’acquisition de la capacité à se reproduire. Plus généralement, les résultats de ce travail de thèse permettent d’identifier de nouveaux mécanismes potentiellement responsables de troubles développementaux dans la mise en place des circuits neuronaux contrôlant l’axe gonadotrope chez les mammifères en général et l’homme en particulier. Nous espérons que ces résultats élargiront notre compréhension de la régulation de l'axe reproducteur, offrant ainsi des possibilités nouvelles de stratégies thérapeutiques contre les troubles de la fertilité
The onset of puberty and the regulation of fertility in mammals are governed by a complex neural network, primarily in the hypothalamus, that converges onto gonadotropin-releasing hormone (GnRH)-producing neurons, the master regulators of gonadotropin secretion and postnatal gonadal growth and function. The proper development of the GnRH system, including timely changes in GnRH expression and signaling by this sparse population of a few hundred neurons, is essential for sexual maturation and the normal functioning of the hypothalamic-pituitary-gonadal axis. As the brain develops during embryogenesis, these neurons should move from the olfactory placode into the correct brain location in adequate numbers, and then establish the afferent connections that will allow the pulsatile release of GnRH peptide, and the subsequent release of the gonadotropins (follicle stimulating hormone, i.e FSH and luteinizing hormone, ie. LH). As early as in the 90’s NO was presented as a key molecule in the preovulatory GnRH/LH surge, and results from different groups, have suggested the interaction of NOS-containing neurons with the GnRH system, and their involvement in the regulation of reproductive capacity. Even though nitric oxide has now been long recognized as a key player in the central hormonal regulation of ovulation during adulthood, no one has considered the possibility that it could act in an earlier stage as the master regulator of GnRH neurons before puberty, hence participating in the actual maturation of the neuroendocrine axis. The relationship of nNOS-expressing neurons with other important molecules of the hypothalamic axis has been well studied, whilst the molecular identity of this neuronal NOS-expressing population is poorly documented. . To this end, we address the hitherto unaddressed questions concerning 1) the molecular identity of nNOS-expressing neurons in the developing hypothalamus, 2) the putative involvement of the NO molecule in the migration of GnRH neurons and the proper establishment of their afferent connections in the hypothalamic region and 3) the plausible determinant role of NO signaling in the maturation of the reproductive system. During this study we identified for the first time the cohort of the principal neurotransmitters and important receptors expressed by these cells in the hypothalamic region during development. Additionally, our results reveal for the first time an involvement of NO signaling in the migration of GnRH neurons in the hypothalamus and are in line with the identification of a series of NOS1 mutations in Kallmann syndrome (KS), a rare congenital genetic condition presenting a unique combination of GnRH deficiency, arising from a faulty migration of the neuronal population, and anosmia. Lastly, our study identifies NO as a novel protagonist during postnatal development, in the regulation of the onset of puberty and the acquisition of reproductive competence. Overall, the results of my Phd thesis identify putative new targets causing alterations of developmental programming under pathophysiological gestational environment in mammals in general, and in humans in particular. Here we thus provide new insights into the mechanisms by which the alteration of GnRH neuronal function leads to hypogonadotropic hypogonadism and infertility. We are hopeful that our results will expand our understanding of how the neuroendocrine axis is regulated and will possibly provide opportunities for therapeutic strategies against debilitating conditions

APA, Harvard, Vancouver, ISO, and other styles

43

Barreiro, Portela Esther. "Study of reactive oxygen species (ROS) and nitric oxide (NO) as molecular mediators of the sepsis-induced diaphragmatic contractile dysfunction : protective effect of heme oxygenases." Doctoral thesis, Universitat Pompeu Fabra, 2002. http://hdl.handle.net/10803/7066.

Full text

Abstract:

Protein nitration is considered as a marker of reactive nitrogen species formation. Heme oxygenases (HOs) are important for the defence against oxidative stress. We evaluated the involvement of the neuronal (nNOS), the endothelial (eNOS), and the inducible (iNOS) in nitrotyrosine formation and localitzation, and both the expression and funcional significance (HO inhibition and contractility studies) of HOs in sepsis-induced muscle contractile dysfunction. Sepsis was elicited by injecting rats and transgenic mice deficient in either nNOS, eNOS, or iNOS isoforms with E.Coli lipolysaccharide (LPS). Nitrotyrosine formation and HO expressions were assessed by immunoblotting. Oxidative stress was assessed measuring protein oxidation, lipid peroxidation, and muscle glutathione. We conclude that protein tyrosine nitration occurs in normal muscles, and sepsis-mediated increase in nitrotyrosine formation is limited to the mitochondria and membrane muscle fractions. The iNOS isoform is mostly involved in nitrotyrosine formation. HOs protect normal and septic muscles from the deleterious effects of oxidants.
En un model de sepsi de disfunció diafragmàtica, s´ha avaluat el paper de les sintetases de l'òxid nítric (NOS) en la formació i localitzacio de 3-nitrotirosina, i l´expressió i significat biològic de les hemo oxigenases (HOs) (inhibidor de les HOs i estudis de contractilitat) davant l' estrès oxidatiu. La sepsi s'induí mitjançant injecció de 20 mg/kg del lipolisacàrid (LPS) d´Escherichia Coli a rates, i a ratolins deficients en les NOS induïble (iNOS), neuronal (nNOS) i endotelial (eNOS). Les proteïnes nitrificades i les HOs es van detectar amb anticossos específics. L' estrès oxidatiu s' avaluà mitjançant l' oxidació proteica, la peroxidació lipídica i el glutation muscular. Concloem que hi han proteïnes nitrificades en el múscul normal i aquestes s'incrementen durant la sepsi en les fraccions mitocondrial i membranar. L'isoforma iNOS és majorment responsable de la formació de nitrotirosina. Les HOs protegirien el múscul normal i sèptic dels efectes deleteris dels oxidants.

APA, Harvard, Vancouver, ISO, and other styles

44

Guilbaud, Marine. "Identification d'ARNs non-codants impliqués dans les dystrophinopathies." Thesis, Sorbonne université, 2018. http://www.theses.fr/2018SORUS042/document.

Full text

Abstract:

Les dystrophies musculaires de Duchenne (DMD) et de Becker (BMD) sont dues à des mutations dans le gène DMD codant la Dystrophine. De nombreux aspects des mécanismes pathophysiologiques de ces maladies ne sont pas encore expliqués. Nous nous sommes intéressés à l'étude d'ARN non-codants pouvant participer à ces processus. Une première étude a été centrée sur l’identification de micro-ARNs (miARNs) impliqués dans la régulation de l’oxyde nitrique synthase neuronale (nNOS) une protéine partenaire de la Dystrophine et associée à des caractéristiques de ces pathologies telles que la fatigabilité musculaire. 617 miARNs ont été criblés par Taqman Low Density Array dans des muscles de sujets sains et de patients BMDdel45-55. 4 miARNs candidats ont été sélectionnés de cette étude pour leur surexpression chez les patients BMDdel45-55 et leur capacité théorique à cibler nNOS. Des expériences de modulation de l’expression de ces miARNs dans des myoblastes humains sains ou dystrophiques nous ont permis d’identifier que le miR-708-5p et le miR-34-5p pouvaient cibler nNOS et moduler son expression.Un deuxième axe a été mené sur l’étude des longs ARNs non-codants (lncARNs). Les introns 44 et 55, qui bornent les exons 45 à 55 délétés chez les patients BMDdel45-55, sont de grandes régions contenant des lncARNs décrits comme régulant la Dystrophine. Les points de cassure introniques des mutations de ces patients n’étant pas décrites, nous avons supposé l’existence de profils de lncARNs différents. L’analyse de l’ADN de ces patients montre en effet des profils de lncARNs différents, révélant ainsi l’importance d’une étude plus précise des zones de délétion des patients BMDdel45-55
Duchenne (DMD) and Becker (BMD) muscular dystrophies are due to mutations in DMD gene, encoding Dystrophin. Many aspects of pathophysiological mechanisms of these diseases are not yet well understood. We were interested in the study of non-coding RNAs that could be involved in these pathological processes. A first study focused on micro-RNAs (miRNAs) that could modulate expression of the neuronal nitric oxide synthase (nNOS), a partner of Dystrophin which is linked to pathological features as muscular fatigability. 617 miRNAs were screened by Taqman Low Density Array in muscle biopsies of healthy subjects or BMDdel45-55 patients. 4 candidate miRNAs were selected from this study since they were overexpressed in BMDdel45-55 patients and for their theoretical ability to target nNOS. Experiments modulating the expression of these miRNAs in healthy or dystrophic human myoblasts enabled us to identify that miR-708-5p and miR-34-5p could target nNOS and modulate its expression.A second axis was conducted on long non-coding RNA (lncRNA). Introns 44 and 55, which bound exons 45-55 deleted in BMDdel45-55 patients, are large regions containing lncRNAs described as regulating Dystrophin. Since intronic breakpoints of DMD mutations of these pateints were not described, we have assumed the existence of different profiles of lncRNAs. DNA analysis of these patients actually showed different lncRNAs profiles, thus revealing the significance of a more precise analysis of deletion areas in DMD gene of BMDdel45-55 patients

APA, Harvard, Vancouver, ISO, and other styles

45

Khadrah, S. "NNS/NNS interaction during task-based synchronous computer-mediated communication." Thesis, University of Manchester, 2007. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.508026.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Bezerra, Paulo Cesar Rego, and Jose Bittencourt de 1937 Andrade. "Sistemas de referencia associados ao NNSS." reponame:Repositório Institucional da UFPR, 2013. http://hdl.handle.net/1884/32062.

Full text

Abstract:

Resumo: O proposito deste trabalho e discutir os conceitos relacionados a definicao e a materializacao dos sistemas de referencia associados ao Navy Navigation Satellite System (NNSS). Sao apresentados todos os principios teoricos necessarios ao completo entendimento desta questao, de um modo tal que eles sao facilmente aplicaveis a outros sitemas de satelites de posicionamento ou de navegacao.

APA, Harvard, Vancouver, ISO, and other styles

47

Iwashita, Noriko. "Comprehensible output in NNS-NNS interaction in Japanese as a foreign language." Connect to thesis, 1993. http://repository.unimelb.edu.au/10187/1523.

Full text

Abstract:

This study is a partial replication of Pica et al’s study (1989) of comprehensible output, and investigates comprehensible output in NNS-NNS interaction in Japanese as a Foreign Language. Data were collected using two different types of tasks (information gap and jigsaw tasks) in three sub-groups of different proficiency levels (High-High, Low-Low, and High-Low) in order to find out (1) to what extent the tasks provide opportunities for learners to modify their initial output in response to requests for clarification and confirmation, and (2) the extent to which learners actually modify their output in response to interlocutor requests.
The results show that comprehensible output is an important phenomenon in NNS-NNS interaction. Unlike the result of Pica et al, task types had more effect on opportunities for comprehensible output and actual production of comprehensible output than request types. Not much difference was found among different proficiency groups.

APA, Harvard, Vancouver, ISO, and other styles

48

Faiglová, Veronika. "Posouzení faktorů úspěšnosti NNO." Master's thesis, Vysoká škola ekonomická v Praze, 2008. http://www.nusl.cz/ntk/nusl-10632.

Full text

Abstract:

The aim of this work is the processing and evaluation of information gained from the questionnaire survey, which took place within the University research. The work is focused on factors that influence the success of NGOs in particular in the areas of activities of organizations and their financing. NGOs are first grouped according to age, geographical scope and legal status. It is also being considered with a vision and mission of their short-term and long-term goals. Another chapter examines the importance of volunteers and their application in different areas of operation. Here is an analysis of the internal control situation, the quality of services and use of information systems. The last task is focused on the allocation of financial resources and evaluation of NGO work with the financial plans.

APA, Harvard, Vancouver, ISO, and other styles

49

Manley, Lucy B. "Embedding the Consultant: A NNES Case Study." Miami University / OhioLINK, 2014. http://rave.ohiolink.edu/etdc/view?acc_num=miami1407853148.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Korený, Jozef. "Faktory efektivity rozvojových programů NNO." Master's thesis, Vysoká škola ekonomická v Praze, 2007. http://www.nusl.cz/ntk/nusl-1011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic 'NNos'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles